BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 048791
(425 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 135 bits (339), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 73/152 (48%), Positives = 95/152 (62%), Gaps = 8/152 (5%)
Query: 277 NLVRFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSA-AGDATFK 335
L RF+ +++ A+ NFS NI+GRGG+G VYKG L DG+ VA+KR K G+ F+
Sbjct: 24 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 336 HEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA--SNGPKLSW 393
EVE+I+ H NL+ LRG+C+ T +R++V M NGSV L + P L W
Sbjct: 84 TEVEMISMAVHRNLLRLRGFCMTPT-----ERLLVYPYMANGSVASCLRERPESQPPLDW 138
Query: 394 PLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
P RQ IALG+ARGLAYLH P I HRD+KA
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 170
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 133 bits (334), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 72/152 (47%), Positives = 94/152 (61%), Gaps = 8/152 (5%)
Query: 277 NLVRFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNC-SAAGDATFK 335
L RF+ +++ A+ NF NI+GRGG+G VYKG L DG VA+KR K + G+ F+
Sbjct: 16 QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 336 HEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA--SNGPKLSW 393
EVE+I+ H NL+ LRG+C+ T+ R++V M NGSV L + P L W
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 394 PLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
P RQ IALG+ARGLAYLH P I HRD+KA
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 61/148 (41%), Positives = 90/148 (60%), Gaps = 10/148 (6%)
Query: 280 RFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVE 339
R D+++AT NF +IG G +G VYKG+L DG++VALKR S+ G F+ E+E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 340 VIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGP--KLSWPLRQ 397
++ RH +LV+L G+C E ++ I++ M+NG++ HL+ S+ P +SW R
Sbjct: 88 TLSFCRHPHLVSLIGFCD-----ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 398 SIALGTARGLAYLHFGAQPAIFHRDIKA 425
I +G ARGL YLH AI HRD+K+
Sbjct: 143 EICIGAARGLHYLH---TRAIIHRDVKS 167
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 61/148 (41%), Positives = 90/148 (60%), Gaps = 10/148 (6%)
Query: 280 RFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVE 339
R D+++AT NF +IG G +G VYKG+L DG++VALKR S+ G F+ E+E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 340 VIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGP--KLSWPLRQ 397
++ RH +LV+L G+C E ++ I++ M+NG++ HL+ S+ P +SW R
Sbjct: 88 TLSFCRHPHLVSLIGFCD-----ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 398 SIALGTARGLAYLHFGAQPAIFHRDIKA 425
I +G ARGL YLH AI HRD+K+
Sbjct: 143 EICIGAARGLHYLH---TRAIIHRDVKS 167
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 58/164 (35%), Positives = 82/164 (50%), Gaps = 26/164 (15%)
Query: 276 TNLVRFTFDDIKKATRNFSR------DNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAA 329
T F+F ++K T NF N +G GG+G VYKG + + + VA+K+ +A
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL---AAM 65
Query: 330 GDAT-------FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDH 382
D T F E++V+A +H NLV L G+ +G +V M NGS+ D
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDR 120
Query: 383 LFASNG-PKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
L +G P LSW +R IA G A G+ +LH HRDIK+
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 161
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 58/164 (35%), Positives = 82/164 (50%), Gaps = 26/164 (15%)
Query: 276 TNLVRFTFDDIKKATRNFSR------DNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAA 329
T F+F ++K T NF N +G GG+G VYKG + + + VA+K+ +A
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL---AAM 65
Query: 330 GDAT-------FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDH 382
D T F E++V+A +H NLV L G+ +G +V M NGS+ D
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDR 120
Query: 383 LFASNG-PKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
L +G P LSW +R IA G A G+ +LH HRDIK+
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 161
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 58/164 (35%), Positives = 82/164 (50%), Gaps = 26/164 (15%)
Query: 276 TNLVRFTFDDIKKATRNFSR------DNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAA 329
T F+F ++K T NF N +G GG+G VYKG + + + VA+K+ +A
Sbjct: 4 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL---AAM 59
Query: 330 GDAT-------FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDH 382
D T F E++V+A +H NLV L G+ +G +V M NGS+ D
Sbjct: 60 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDR 114
Query: 383 LFASNG-PKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
L +G P LSW +R IA G A G+ +LH HRDIK+
Sbjct: 115 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 155
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 57/164 (34%), Positives = 78/164 (47%), Gaps = 26/164 (15%)
Query: 276 TNLVRFTFDDIKKATRNFSR------DNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAA 329
T F+F ++K T NF N G GG+G VYKG + + + VA+K+ +A
Sbjct: 1 TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKL---AAM 56
Query: 330 GDAT-------FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDH 382
D T F E++V A +H NLV L G+ +G +V NGS+ D
Sbjct: 57 VDITTEELKQQFDQEIKVXAKCQHENLVELLGFSS-----DGDDLCLVYVYXPNGSLLDR 111
Query: 383 LFASNG-PKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
L +G P LSW R IA G A G+ +LH HRDIK+
Sbjct: 112 LSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKS 152
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 45/127 (35%), Positives = 58/127 (45%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY A
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL AS K IA TARG+ YLH +I
Sbjct: 92 P------QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 142 IHRDLKS 148
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 44/127 (34%), Positives = 57/127 (44%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 20 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL AS K IA TARG+ YLH +I
Sbjct: 80 P------QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSI 129
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 130 IHRDLKS 136
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 44/127 (34%), Positives = 57/127 (44%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL AS K IA TARG+ YLH +I
Sbjct: 92 P------QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 142 IHRDLKS 148
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 13/138 (9%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCS----AAGDATFKHEVEVIASVRHV 347
+ + IIG GG+G VY+ G EVA+K ++ + + E ++ A ++H
Sbjct: 8 ELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N++ALRG C+ L +V + + G + L +G ++ + + A+ ARG+
Sbjct: 67 NIIALRGVCLKEPNL-----CLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGM 118
Query: 408 AYLHFGAQPAIFHRDIKA 425
YLH A I HRD+K+
Sbjct: 119 NYLHDEAIVPIIHRDLKS 136
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 42/127 (33%), Positives = 56/127 (44%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY A
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 76 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 126 IHRDLKS 132
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/136 (35%), Positives = 75/136 (55%), Gaps = 19/136 (13%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV--RHVNLVALRGYC 356
IG+G +G V++G G EVA+K F S+ + ++ E E+ +V RH N++ G+
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 102
Query: 357 IATTQLEGH--QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF-- 412
A + G Q +V D ++GS++D+L N ++ +AL TA GLA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 413 -GAQ--PAIFHRDIKA 425
G Q PAI HRD+K+
Sbjct: 160 VGTQGKPAIAHRDLKS 175
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/136 (35%), Positives = 75/136 (55%), Gaps = 19/136 (13%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV--RHVNLVALRGYC 356
IG+G +G V++G G EVA+K F S+ + ++ E E+ +V RH N++ G+
Sbjct: 12 IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 64
Query: 357 IATTQLEGH--QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF-- 412
A + G Q +V D ++GS++D+L N ++ +AL TA GLA+LH
Sbjct: 65 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 413 -GAQ--PAIFHRDIKA 425
G Q PAI HRD+K+
Sbjct: 122 VGTQGKPAIAHRDLKS 137
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/136 (35%), Positives = 75/136 (55%), Gaps = 19/136 (13%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV--RHVNLVALRGYC 356
IG+G +G V++G G EVA+K F S+ + ++ E E+ +V RH N++ G+
Sbjct: 37 IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 89
Query: 357 IATTQLEGH--QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF-- 412
A + G Q +V D ++GS++D+L N ++ +AL TA GLA+LH
Sbjct: 90 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 146
Query: 413 -GAQ--PAIFHRDIKA 425
G Q PAI HRD+K+
Sbjct: 147 VGTQGKPAIAHRDLKS 162
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/136 (35%), Positives = 75/136 (55%), Gaps = 19/136 (13%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV--RHVNLVALRGYC 356
IG+G +G V++G G EVA+K F S+ + ++ E E+ +V RH N++ G+
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 63
Query: 357 IATTQLEGH--QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF-- 412
A + G Q +V D ++GS++D+L N ++ +AL TA GLA+LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 413 -GAQ--PAIFHRDIKA 425
G Q PAI HRD+K+
Sbjct: 121 VGTQGKPAIAHRDLKS 136
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 17/145 (11%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKG-LLPDGSEVALKRFKNCSAAGDA-------TFKHEVEV 340
A + IG+GG+G V+KG L+ D S VA+K + G+ F+ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 341 IASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA 400
++++ H N+V L G ++ V + + G +Y L P + W ++ +
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPRM-------VMEFVPCGDLYHRLLDKAHP-IKWSVKLRLM 128
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
L A G+ Y+ P I HRD+++
Sbjct: 129 LDIALGIEYMQ-NQNPPIVHRDLRS 152
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 48/136 (35%), Positives = 75/136 (55%), Gaps = 19/136 (13%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV--RHVNLVALRGYC 356
IG+G +G V++G G EVA+K F S+ + ++ E E+ +V RH N++ G+
Sbjct: 14 IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 66
Query: 357 IATTQLEGH--QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF-- 412
A + G Q +V D ++GS++D+L N ++ +AL TA GLA+LH
Sbjct: 67 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 413 -GAQ--PAIFHRDIKA 425
G Q PAI HRD+K+
Sbjct: 124 VGTQGKPAIAHRDLKS 139
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 48/136 (35%), Positives = 75/136 (55%), Gaps = 19/136 (13%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV--RHVNLVALRGYC 356
IG+G +G V++G G EVA+K F S+ + ++ E E+ +V RH N++ G+
Sbjct: 17 IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 69
Query: 357 IATTQLEGH--QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF-- 412
A + G Q +V D ++GS++D+L N ++ +AL TA GLA+LH
Sbjct: 70 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 413 -GAQ--PAIFHRDIKA 425
G Q PAI HRD+K+
Sbjct: 127 VGTQGKPAIAHRDLKS 142
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 62/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IVC+ M GS+ D L G L P +A A G+AY+ +
Sbjct: 83 SEE----PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 136 VHRDLRA 142
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 17/145 (11%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKG-LLPDGSEVALKRFKNCSAAGDA-------TFKHEVEV 340
A + IG+GG+G V+KG L+ D S VA+K + G+ F+ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 341 IASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA 400
++++ H N+V L G ++ V + + G +Y L P + W ++ +
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPRM-------VMEFVPCGDLYHRLLDKAHP-IKWSVKLRLM 128
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
L A G+ Y+ P I HRD+++
Sbjct: 129 LDIALGIEYMQ-NQNPPIVHRDLRS 152
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 17/145 (11%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKG-LLPDGSEVALKRFKNCSAAGDA-------TFKHEVEV 340
A + IG+GG+G V+KG L+ D S VA+K + G+ F+ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 341 IASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA 400
++++ H N+V L G ++ V + + G +Y L P + W ++ +
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPRM-------VMEFVPCGDLYHRLLDKAHP-IKWSVKLRLM 128
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
L A G+ Y+ P I HRD+++
Sbjct: 129 LDIALGIEYMQ-NQNPPIVHRDLRS 152
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 42/130 (32%), Positives = 62/130 (47%), Gaps = 10/130 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRF--KNCSAAGDATFKHEVEVIASVRHVNLVALRGYC 356
IG G +G V++ GS+VA+K ++ A F EV ++ +RH N+V G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNG-PKLSWPLRQSIALGTARGLAYLHFGAQ 415
L IV + + GS+Y L S +L R S+A A+G+ YLH
Sbjct: 104 TQPPNLS-----IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 416 PAIFHRDIKA 425
P I HRD+K+
Sbjct: 158 PPIVHRDLKS 167
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 21/149 (14%)
Query: 287 KKATRNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV-- 344
+ R+ + +G+G YG V++G G VA+K F S+ + ++ E E+ +V
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVML 59
Query: 345 RHVNLVALRGYCIATTQLEGH---QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
RH N++ IA+ H Q ++ + GS+YD+L + +S LR I L
Sbjct: 60 RHENILGF----IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS-CLR--IVL 112
Query: 402 GTARGLAYLH---FGAQ--PAIFHRDIKA 425
A GLA+LH FG Q PAI HRD+K+
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKS 141
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 76 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 126 IHRDLKS 132
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 76 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 126 IHRDLKS 132
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 81 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 130
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 131 IHRDLKS 137
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 81 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 130
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 131 IHRDLKS 137
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 18 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 78 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 127
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 128 IHRDLKS 134
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 36 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 96 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 145
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 146 IHRDLKS 152
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 104 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 153
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 154 IHRDLKS 160
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 43 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 103 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 152
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 153 IHRDLKS 159
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + FK+EV V+ RHVN++ GY
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
Q IV + S+Y HL K IA TA+G+ YLH +I
Sbjct: 104 P------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSI 153
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 154 IHRDLKS 160
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/137 (35%), Positives = 72/137 (52%), Gaps = 21/137 (15%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV--RHVNLVALRGYC 356
+G+G YG V++G G VA+K F S+ + ++ E E+ +V RH N++
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGF---- 67
Query: 357 IATTQLEGH---QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLH-- 411
IA+ H Q ++ + GS+YD+L + +S LR I L A GLA+LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS-CLR--IVLSIASGLAHLHIE 124
Query: 412 -FGAQ--PAIFHRDIKA 425
FG Q PAI HRD+K+
Sbjct: 125 IFGTQGKPAIAHRDLKS 141
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 21/149 (14%)
Query: 287 KKATRNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV-- 344
+ R + +G+G YG V++G G VA+K F S+ + ++ E E+ +V
Sbjct: 33 RTVARQITLLECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVML 88
Query: 345 RHVNLVALRGYCIATTQLEGH---QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
RH N++ IA+ H Q ++ + GS+YD+L + +S LR I L
Sbjct: 89 RHENILGF----IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS-CLR--IVL 141
Query: 402 GTARGLAYLH---FGAQ--PAIFHRDIKA 425
A GLA+LH FG Q PAI HRD+K+
Sbjct: 142 SIASGLAHLHIEIFGTQGKPAIAHRDLKS 170
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 57/127 (44%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G VYKG V + + + + F++EV V+ RHVN++ GY
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY--- 100
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ IV + S+Y HL + L IA TA+G+ YLH I
Sbjct: 101 ---MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTAQGMDYLH---AKNI 153
Query: 419 FHRDIKA 425
HRD+K+
Sbjct: 154 IHRDMKS 160
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 249 SEE----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 302 VHRDLRA 308
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 249 SEE----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 302 VHRDLRA 308
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 41/130 (31%), Positives = 62/130 (47%), Gaps = 10/130 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRF--KNCSAAGDATFKHEVEVIASVRHVNLVALRGYC 356
IG G +G V++ GS+VA+K ++ A F EV ++ +RH N+V G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNG-PKLSWPLRQSIALGTARGLAYLHFGAQ 415
L IV + + GS+Y L S +L R S+A A+G+ YLH
Sbjct: 104 TQPPNLS-----IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 416 PAIFHRDIKA 425
P I HR++K+
Sbjct: 158 PPIVHRNLKS 167
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 72
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 73 SEE----PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 125
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 126 VHRDLRA 132
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 19/136 (13%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV--RHVNLVALRGYC 356
IG+G YG V+ G G +VA+K F +A++ E E+ +V RH N++ G+
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENIL---GFI 97
Query: 357 IATTQLEGH--QRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLH--- 411
A + G Q ++ D +NGS+YD+L ++ L +A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 412 FGAQ--PAIFHRDIKA 425
F Q PAI HRD+K+
Sbjct: 155 FSTQGKPAIAHRDLKS 170
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 86
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 87 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 139
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 140 IHRDLRA 146
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 83
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 84 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 136
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 137 IHRDLRA 143
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 83 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 135
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 136 IHRDLRA 142
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 75
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 76 SEE----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 128
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 129 VHRDLRA 135
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 83
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 84 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 136
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 137 IHRDLRA 143
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 78
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 79 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 131
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 132 IHRDLRA 138
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 17/147 (11%)
Query: 287 KKATRNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV-- 344
+ R + +G+G YG V++GL G VA+K F S+ + ++ E E+ +V
Sbjct: 4 RTVARQVALVECVGKGRYGEVWRGLW-HGESVAVKIF---SSRDEQSWFRETEIYNTVLL 59
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN-GPKLSWPLRQSIALGT 403
RH N++ + T++ Q ++ ++GS+YD L P L+ LR +A+
Sbjct: 60 RHDNILGFIASDM-TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA--LR--LAVSA 114
Query: 404 ARGLAYLH---FGAQ--PAIFHRDIKA 425
A GLA+LH FG Q PAI HRD K+
Sbjct: 115 ACGLAHLHVEIFGTQGKPAIAHRDFKS 141
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 77
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 78 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 131 IHRDLRA 137
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 79
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 80 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 132
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 133 IHRDLRA 139
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 77
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 78 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 131 IHRDLRA 137
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 85
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 86 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 138
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 139 IHRDLRA 145
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 77
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 78 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 131 IHRDLRA 137
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 72
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 73 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 125
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 126 IHRDLRA 132
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 83 SEE----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 136 VHRDLRA 142
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 87
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 88 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 140
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 141 IHRDLRA 147
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 249 SEE----PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 302 VHRDLRA 308
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 71
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 72 SEE----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 124
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 125 VHRDLRA 131
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 331
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 332 SEE----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 385 VHRDLRA 391
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 73
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 74 SEE----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 126
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 127 VHRDLRA 133
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 83 SEE----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 136 VHRDLRA 142
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 83 SEE----PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 136 VHRDLRA 142
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P ++ A G+AY+ +
Sbjct: 80 SEE----PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNY 132
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 133 VHRDLRA 139
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 83 SEE----PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 136 VHRDLRA 142
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P ++ A G+AY+ +
Sbjct: 80 SEE----PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNY 132
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 133 VHRDLRA 139
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 249
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 250 SEE----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 302
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 303 VHRDLRA 309
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/127 (31%), Positives = 60/127 (47%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG G +G V+ G + +VA+K K S + D F E EV+ + H LV L G C
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGVC-- 91
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
LE +V + M++G + D+L G + L + L G+AYL + +
Sbjct: 92 ---LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLE---EACV 144
Query: 419 FHRDIKA 425
HRD+ A
Sbjct: 145 IHRDLAA 151
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 60/127 (47%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 83 SEE----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 419 FHRDIKA 425
HRD+ A
Sbjct: 136 VHRDLAA 142
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 73
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 74 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 126
Query: 419 FHRDIKA 425
HR+++A
Sbjct: 127 IHRNLRA 133
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLV 350
+ + ++GRG +G V K +VA+K+ + S + F E+ ++ V H N+V
Sbjct: 9 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 65
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNG-PKLSWPLRQSIALGTARGLAY 409
L G C+ L V + + GS+Y+ L + P + S L ++G+AY
Sbjct: 66 KLYGACLNPVCL-------VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 118
Query: 410 LHFGAQPAIFHRDIK 424
LH A+ HRD+K
Sbjct: 119 LHSMQPKALIHRDLK 133
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G + ++VA+K K + + A F E ++ +++H LV L Y +
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRL--YAVV 76
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M GS+ D L + G K+ P + A G+AY+ +
Sbjct: 77 TKE---EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNY 130
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 131 IHRDLRA 137
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G G V+ G ++VA+K K S + DA F E ++ ++H LV L Y +
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL--YAVV 77
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M+NGS+ D L +G KL+ +A A G+A++ +
Sbjct: 78 TQE----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 131 IHRDLRA 137
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLV 350
+ + ++GRG +G V K +VA+K+ + S + F E+ ++ V H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNG-PKLSWPLRQSIALGTARGLAY 409
L G C+ L V + + GS+Y+ L + P + S L ++G+AY
Sbjct: 65 KLYGACLNPVCL-------VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 410 LHFGAQPAIFHRDIK 424
LH A+ HRD+K
Sbjct: 118 LHSMQPKALIHRDLK 132
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G + ++VA+K K + + A F E ++ +++H LV L Y +
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRL--YAVV 77
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M GS+ D L + G K+ P + A G+AY+ +
Sbjct: 78 TRE---EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNY 131
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 132 IHRDLRA 138
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M G + D L G L P +A A G+AY+ +
Sbjct: 83 SEE----PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 136 VHRDLRA 142
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G+G +G V+ G + VA+K K + + +A F E +V+ +RH LV L Y +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M G + D L G L P +A A G+AY+ +
Sbjct: 83 SEE----PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 136 VHRDLRA 142
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 281 FTFDDIKKATRNFSR---------DNIIGRGGYGNVYKG--LLPDGSE--VALKRFKN-C 326
FTF+D +A R F++ + +IG G +G V G LP E VA+K K+
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 327 SAAGDATFKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFAS 386
+ F E ++ H N++ L G +T + +I+ + M+NGS+ D
Sbjct: 74 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-----MIITEFMENGSL-DSFLRQ 127
Query: 387 NGPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
N + + + G A G+ YL A HRD+ A
Sbjct: 128 NDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAA 163
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 34/127 (26%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ G ++VA+K K + + + +F E +++ ++H LV L Y +
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQL--YAVV 73
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
+ + IV + M GS+ D L G L P +A A G+AY+ +
Sbjct: 74 SEE----PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNY 126
Query: 419 FHRDIKA 425
HRD+++
Sbjct: 127 IHRDLRS 133
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 63
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N ++S + +A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAA 139
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 63
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N ++S + +A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAA 139
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + F E V+
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 63
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N ++S + +A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAA 139
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + F E V+
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 68
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N ++S + +A
Sbjct: 69 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 124 QISSAMEYLE---KKNFIHRDLAA 144
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + F E V+
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 63
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N ++S + +A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAA 139
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 18/141 (12%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGS----EVALKRFKNCSA-AGDATFKHEVEVIASVR 345
R ++G G +G VYKG+ +P+G VA+K + + F E ++AS+
Sbjct: 16 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 346 HVNLVALRGYCIA-TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTA 404
H +LV L G C++ T QL V LM +G + +++ + L + + A
Sbjct: 76 HPHLVRLLGVCLSPTIQL-------VTQLMPHGCLLEYVHEHKD-NIGSQLLLNWCVQIA 127
Query: 405 RGLAYLHFGAQPAIFHRDIKA 425
+G+ YL + + HRD+ A
Sbjct: 128 KGMMYLE---ERRLVHRDLAA 145
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 10/146 (6%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVE 339
+ D + + + + +G G YG VY+G+ S VA+K K + + K E
Sbjct: 1 MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAA 59
Query: 340 VIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSI 399
V+ ++H NLV L G C I+ + M G++ D+L N ++S + +
Sbjct: 60 VMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 400 ALGTARGLAYLHFGAQPAIFHRDIKA 425
A + + YL + HRD+ A
Sbjct: 115 ATQISSAMEYLE---KKNFIHRDLAA 137
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 18/141 (12%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGS----EVALKRFKNCSA-AGDATFKHEVEVIASVR 345
R ++G G +G VYKG+ +P+G VA+K + + F E ++AS+
Sbjct: 39 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 346 HVNLVALRGYCIA-TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTA 404
H +LV L G C++ T QL V LM +G + +++ + L + + A
Sbjct: 99 HPHLVRLLGVCLSPTIQL-------VTQLMPHGCLLEYVHEHKD-NIGSQLLLNWCVQIA 150
Query: 405 RGLAYLHFGAQPAIFHRDIKA 425
+G+ YL + + HRD+ A
Sbjct: 151 KGMMYLE---ERRLVHRDLAA 168
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 37/145 (25%), Positives = 64/145 (44%), Gaps = 10/145 (6%)
Query: 282 TFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEV 340
+ D + + + + +G G YG VY+G+ S VA+K K + + K E V
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAV 60
Query: 341 IASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA 400
+ ++H NLV L G C I+ + M G++ D+L N ++S + +A
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 115
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 116 TQISSAMEYLE---KKNFIHRDLAA 137
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 68
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 69 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 124 QISSAMEYLE---KKNFIHRDLAA 144
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 63
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAA 139
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 68
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 69 KEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 124 QISSAMEYLE---KKNFIHRDLAA 144
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 18 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 76
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 77 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 132 QISSAMEYLE---KKNFIHRDLAA 152
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 67
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 68 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAA 143
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 68
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 69 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 124 QISSAMEYLE---KKNFIHRDLAA 144
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + F E V+
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 64
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 65 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 120 QISSAMEYLE---KKNFIHRDLAA 140
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + F E V+
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 63
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAA 139
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + F E V+
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 65
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 66 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 121 QISSAMEYLE---KKNFIHRDLAA 141
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 296 DNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGY 355
+ +G G +G V+ ++VA+K K S + +A F E V+ +++H LV L +
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL--H 243
Query: 356 CIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQ 415
+ T + I+ + M GS+ D L + G K P + A G+A++ Q
Sbjct: 244 AVVTKE----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 296
Query: 416 PAIFHRDIKA 425
HRD++A
Sbjct: 297 RNYIHRDLRA 306
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + F E V+
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 68
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 69 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 124 QISSAMEYLE---KKNFIHRDLAA 144
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + F E V+
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVM 65
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 66 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 121 QISSAMEYLE---KKNFIHRDLAA 141
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 65
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 66 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 121 QISSAMEYLE---KKNFIHRDLAA 141
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 64
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 65 KEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HRD+ A
Sbjct: 120 QISSAMEYLE---KKNFIHRDLAA 140
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 296 DNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGY 355
+ +G G +G V+ ++VA+K K S + +A F E V+ +++H LV L +
Sbjct: 20 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL--H 76
Query: 356 CIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQ 415
+ T + I+ + M GS+ D L + G K P + A G+A++ Q
Sbjct: 77 AVVTKE----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 129
Query: 416 PAIFHRDIKA 425
HRD++A
Sbjct: 130 RNYIHRDLRA 139
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 39/152 (25%), Positives = 66/152 (43%), Gaps = 10/152 (6%)
Query: 275 STNLVRFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDAT 333
+ NL + D + + + + +G G YG VY G+ S VA+K K + +
Sbjct: 16 TENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE- 74
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E V+ ++H NLV L G C IV + M G++ D+L N +++
Sbjct: 75 FLKEAAVMKEIKHPNLVQLLGVCTLEPPF-----YIVTEYMPYGNLLDYLRECNREEVTA 129
Query: 394 PLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
+ +A + + YL + HRD+ A
Sbjct: 130 VVLLYMATQISSAMEYLE---KKNFIHRDLAA 158
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 60/127 (47%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
+G G +G V+ ++VA+K K S + +A F E V+ +++H LV L + +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL--HAVV 252
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
T + I+ + M GS+ D L + G K P + A G+A++ Q
Sbjct: 253 TKE----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305
Query: 419 FHRDIKA 425
HRD++A
Sbjct: 306 IHRDLRA 312
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 43/140 (30%), Positives = 63/140 (45%), Gaps = 21/140 (15%)
Query: 297 NIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEV--IASVRHVNLVALRG 354
+IGRG YG VYKG L D VA+K F S A F +E + + + H N+
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIAR--- 71
Query: 355 YCIATTQLEGHQR---IIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLH 411
+ + ++ R ++V + NGS+ +L W +A RGLAYLH
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLAYLH 128
Query: 412 FGA------QPAIFHRDIKA 425
+PAI HRD+ +
Sbjct: 129 TELPRGDHYKPAISHRDLNS 148
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 36/146 (24%), Positives = 64/146 (43%), Gaps = 10/146 (6%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVE 339
+ D + + + + +G G +G VY+G+ S VA+K K + + F E
Sbjct: 1 MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAA 59
Query: 340 VIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSI 399
V+ ++H NLV L G C I+ + M G++ D+L N ++S + +
Sbjct: 60 VMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 400 ALGTARGLAYLHFGAQPAIFHRDIKA 425
A + + YL + HRD+ A
Sbjct: 115 ATQISSAMEYLE---KKNFIHRDLAA 137
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 16/135 (11%)
Query: 297 NIIGRGGYGNVYKGL-LPDGSE----VALKRFK-NCSAAGDATFKHEVEVIASVRHVNLV 350
++G G +G VYKG+ +PDG VA+K + N S + E V+A V +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
L G C+ +T +V LM G + DH+ + G +L + + A+G++YL
Sbjct: 83 RLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRG-RLGSQDLLNWCMQIAKGMSYL 135
Query: 411 HFGAQPAIFHRDIKA 425
+ HRD+ A
Sbjct: 136 E---DVRLVHRDLAA 147
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 270
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N ++S + +A
Sbjct: 271 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HR++ A
Sbjct: 326 QISSAMEYLE---KKNFIHRNLAA 346
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 296 DNIIGRGGYGNVYKGLLPDGS-EVALKRFKN--CSAAGDATFKHEVEVIASVRHVNLVAL 352
D IGRG + VYKGL + + EVA ++ + + FK E E + ++H N+V
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIV-- 88
Query: 353 RGYCIATTQLEGHQRII-VCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLH 411
R Y + ++G + I+ V +L +G++ +L K+ + +S +GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIK--VLRSWCRQILKGLQFLH 146
Query: 412 FGAQPAIFHRDIK 424
P I HRD+K
Sbjct: 147 -TRTPPIIHRDLK 158
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 19/140 (13%)
Query: 294 SRDNIIGRGGYGNVYKGLLPDGS-----EVALKRFK-NCSAAGDATFKHEVEVIASVRHV 347
+R +IG G +G VYKG+L S VA+K K + F E ++ H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL--GTAR 405
N++ L G + +I+ + M+NG++ L +G + + Q + + G A
Sbjct: 107 NIIRLEGVISKYKPM-----MIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAA 158
Query: 406 GLAYLHFGAQPAIFHRDIKA 425
G+ YL A HRD+ A
Sbjct: 159 GMKYL---ANMNYVHRDLAA 175
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 15/140 (10%)
Query: 297 NIIGRGGYGNVYKGLLP--DGS--EVALKRFK--NCSAAGDATFKHEVEVIASVRHVNLV 350
I+G G +G+V +G L DG+ +VA+K K N S F E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFAS---NGPKLSWPLRQ--SIALGTAR 405
L G CI + + +++ MK G ++ +L S GPK PL+ + A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK-HIPLQTLLKFMVDIAL 158
Query: 406 GLAYLHFGAQPAIFHRDIKA 425
G+ YL + HRD+ A
Sbjct: 159 GMEYL---SNRNFLHRDLAA 175
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 35 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ + H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 95 FLMEALIISKLNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 148
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 183
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/129 (26%), Positives = 53/129 (41%), Gaps = 9/129 (6%)
Query: 297 NIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYC 356
+IG+G +G VY G + L + + FK EV RH N+V G C
Sbjct: 39 ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQP 416
++ L I+ L K ++Y + L + IA +G+ YLH
Sbjct: 99 MSPPHL-----AIITSLCKGRTLYS-VVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 417 AIFHRDIKA 425
I H+D+K+
Sbjct: 150 GILHKDLKS 158
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 21 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ + H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 81 FLMEALIISKLNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 134
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 169
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 37 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 96
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 97 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 150
Query: 394 P--LRQSIALGTARGLAY-LHFGAQPAIFHRDIKA 425
P L L AR +A + + HRDI A
Sbjct: 151 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 185
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/135 (25%), Positives = 56/135 (41%), Gaps = 5/135 (3%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASV-RHVNLVA 351
F ++G G YG VYKG ++A + + + + K E+ ++ H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 352 LRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
G I ++ +V + GSV D + + G L I RGL++L
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 411 HFGAQPAIFHRDIKA 425
H Q + HRDIK
Sbjct: 146 H---QHKVIHRDIKG 157
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 61 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 121 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 174
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 209
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 47 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 106
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 107 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 160
Query: 394 P--LRQSIALGTARGLAY-LHFGAQPAIFHRDIKA 425
P L L AR +A + + HRDI A
Sbjct: 161 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 195
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/144 (24%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 209 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 267
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 268 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 322
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HR++ A
Sbjct: 323 QISSAMEYLE---KKNFIHRNLAA 343
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 80 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 133
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 168
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 80 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILMELMAGGDLKSFLRETR-PRPSQ 133
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 168
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 21 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 81 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 134
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 169
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 35 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 95 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILMELMAGGDLKSFLRETR-PRPSQ 148
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 183
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 27 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 86
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 87 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 140
Query: 394 P--LRQSIALGTARGLAY-LHFGAQPAIFHRDIKA 425
P L L AR +A + + HRDI A
Sbjct: 141 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 175
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 35/144 (24%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 283 FDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDATFKHEVEVI 341
+D + + + + +G G YG VY+G+ S VA+K K + + K E V+
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVM 309
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H NLV L G C I+ + M G++ D+L N +++ + +A
Sbjct: 310 KEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 402 GTARGLAYLHFGAQPAIFHRDIKA 425
+ + YL + HR++ A
Sbjct: 365 QISSAMEYLE---KKNFIHRNLAA 385
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 21 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 81 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 134
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 169
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 12 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 72 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 125
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 126 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 160
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKN-CSAAGDAT 333
+ D+K+ R N + +G G +G VY+G + P +VA+K CS +
Sbjct: 38 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 97
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 98 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 151
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 152 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 186
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 17/138 (12%)
Query: 297 NIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEV--IASVRHVNLVALRG 354
+ RG +G V+K L + VA+K F ++++E EV + ++H N++ G
Sbjct: 30 EVKARGRFGCVWKAQLLN-EYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 355 YCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF-- 412
T ++ +I + GS+ D L A+ +SW IA ARGLAYLH
Sbjct: 86 AEKRGTSVDVDLWLITA-FHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDI 141
Query: 413 -----GAQPAIFHRDIKA 425
G +PAI HRDIK+
Sbjct: 142 PGLKDGHKPAISHRDIKS 159
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGL-LPDGSEVALKRFKNCSAAGD-ATFKHEVEVIASVRH 346
++ F + +G G Y VYKGL G VALK K S G +T E+ ++ ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNG--SVYDHLFASNGPK-LSWPLRQSIALGT 403
N+V L Y + T+ ++ +V + M N D N P+ L L +
Sbjct: 63 ENIVRL--YDVIHTE---NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 404 ARGLAYLHFGAQPAIFHRDIK 424
+GLA+ H + I HRD+K
Sbjct: 118 LQGLAFCH---ENKILHRDLK 135
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 76 NPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYLLNW------C 123
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 124 VQIAKGMNYLE---DRRLVHRDLAA 145
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 31/112 (27%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 315 GSEVALKRFKNCSAAGD-ATFKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDL 373
G +VA+K K S A K E+E++ ++ H N+V +G C T+ G+ ++ +
Sbjct: 38 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC---TEDGGNGIKLIMEF 94
Query: 374 MKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
+ +GS+ ++L N K++ + A+ +G+ YL G++ + HRD+ A
Sbjct: 95 LPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAA 142
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 31/112 (27%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 315 GSEVALKRFKNCSAAGD-ATFKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDL 373
G +VA+K K S A K E+E++ ++ H N+V +G C T+ G+ ++ +
Sbjct: 50 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC---TEDGGNGIKLIMEF 106
Query: 374 MKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
+ +GS+ ++L N K++ + A+ +G+ YL G++ + HRD+ A
Sbjct: 107 LPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAA 154
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 56/127 (44%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG+G +G+V G G++VA+K KN + A F E V+ +RH NLV L G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
E IV + M GS+ D+L + L +L + YL
Sbjct: 71 ----EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 419 FHRDIKA 425
HRD+ A
Sbjct: 124 VHRDLAA 130
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 77 NPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQYLLNW------C 124
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 125 VQIAKGMNYLE---DRRLVHRDLAA 146
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 23/159 (14%)
Query: 281 FTFDDIKKATRNFSR---------DNIIGRGGYGNVYKGLL--PDGSE--VALKRFK-NC 326
FTF+D +A R F++ + +IG G +G V G L P E VA+K K
Sbjct: 10 FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 327 SAAGDATFKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFAS 386
+ F E ++ H N++ L G + +I+ + M+NGS+ D
Sbjct: 70 TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPV-----MIITEYMENGSL-DAFLRK 123
Query: 387 NGPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
N + + + G G+ YL + + HRD+ A
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAA 159
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 56/127 (44%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG+G +G+V G G++VA+K KN + A F E V+ +RH NLV L G +
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
E IV + M GS+ D+L + L +L + YL
Sbjct: 258 ----EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 419 FHRDIKA 425
HRD+ A
Sbjct: 311 VHRDLAA 317
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 56/127 (44%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG+G +G+V G G++VA+K KN + A F E V+ +RH NLV L G +
Sbjct: 20 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
E IV + M GS+ D+L + L +L + YL
Sbjct: 77 ----EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 419 FHRDIKA 425
HRD+ A
Sbjct: 130 VHRDLAA 136
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 26 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 86 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 133
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 134 VQIAKGMNYLE---DRRLVHRDLAA 155
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 56/127 (44%), Gaps = 10/127 (7%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIA 358
IG+G +G+V G G++VA+K KN + A F E V+ +RH NLV L G +
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 359 TTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAI 418
E IV + M GS+ D+L + L +L + YL
Sbjct: 86 ----EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 419 FHRDIKA 425
HRD+ A
Sbjct: 139 VHRDLAA 145
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 76 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 124 VQIAKGMNYLE---DRRLVHRDLAA 145
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 76 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 124 VQIAKGMNYLE---DRRLVHRDLAA 145
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 77 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 124
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 125 VQIAKGMNYLE---DRRLVHRDLAA 146
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 79 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 127 VQIAKGMNYLE---DRRLVHRDLAA 148
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 76 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 124 VQIAKGMNYLE---DRRLVHRDLAA 145
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 79 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 127 VQIAKGMNYLE---DRRLVHRDLAA 148
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 70 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 117
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 118 VQIAKGMNYLE---DRRLVHRDLAA 139
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 78 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 126 VQIAKGMNYLE---DRRLVHRDLAA 147
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 80 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 127
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 128 VQIAKGMNYLE---DRRLVHRDLAA 149
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 41 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 101 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 148
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 149 VQIAKGMNYLE---DRRLVHRDLAA 170
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 79 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 127 VQIAKGMNYLE---DRRLVHRDLAA 148
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 76 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 124 VQIAKGMNYLE---DRRLVHRDLAA 145
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 22 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 82 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 129
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 130 VQIAKGMNYLE---DRRLVHRDLAA 151
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 83 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 131 VQIAKGMNYLE---DRRLVHRDLAA 152
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 78 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 126 VQIAKGMNYLE---DRRLVHRDLAA 147
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 78 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 126 VQIAKGMNYLE---DRRLVHRDLAA 147
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 79 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 127 VQIAKGMNYLE---DRRLVHRDLAA 148
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 80 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 127
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 128 VQIAKGMNYLE---DRRLVHRDLAA 149
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 78 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 126 VQIAKGMNYLE---DRRLVHRDLAA 147
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 83 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 131 VQIAKGMNYLE---DRRLVHRDLAA 152
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 78 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 126 VQIAKGMNYLE---DRRLVHRDLAA 147
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 54 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 114 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 167
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 168 L---ASKKFVHRDLAA 180
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 34 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 94 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 147
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 148 L---ASKKFVHRDLAA 160
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 53 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 113 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 166
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 167 L---ASKKFVHRDLAA 179
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 33/130 (25%), Positives = 55/130 (42%), Gaps = 10/130 (7%)
Query: 297 NIIGRGGYGNVYKGLLPDGSEV-ALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGY 355
++G+G +G K + EV +K TF EV+V+ + H N++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 356 CIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQ 415
+L + + +K G++ + S + W R S A A G+AYLH
Sbjct: 76 LYKDKRLN-----FITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLH---S 126
Query: 416 PAIFHRDIKA 425
I HRD+ +
Sbjct: 127 MNIIHRDLNS 136
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 95 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 148
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 149 L---ASKKFVHRDLAA 161
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 92 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 145
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 146 L---ASKKFVHRDLAA 158
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 95 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 148
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 149 L---ASKKFVHRDLAA 161
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 34 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 94 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 147
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 148 L---ASKKFVHRDLAA 160
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 27 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 87 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 140
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 141 L---ASKKFVHRDLAA 153
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 90 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 143
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 144 L---ASKKFVHRDLAA 156
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 33 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ Y
Sbjct: 93 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKY 146
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 147 L---ASKKFVHRDLAA 159
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 66/145 (45%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 13 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 73 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 120
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A G+ YL + HRD+ A
Sbjct: 121 VQIAEGMNYLE---DRRLVHRDLAA 142
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 20/148 (13%)
Query: 285 DIKKATRNFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFK--NCSAAGDA---TFKHEV 338
D+K + + + + +G G + VYK + ++ VA+K+ K + S A D T E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 339 EVIASVRHVNLVALRGYCIATTQLEGHQRII--VCDLMKNGSVYDHLFASNGPKLSWPLR 396
+++ + H N++ L GH+ I V D M+ + + N L+
Sbjct: 64 KLLQELSHPNIIGLLDAF-------GHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHI 114
Query: 397 QSIALGTARGLAYLHFGAQPAIFHRDIK 424
++ L T +GL YLH Q I HRD+K
Sbjct: 115 KAYMLMTLQGLEYLH---QHWILHRDLK 139
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L A L Q + +G+ YL
Sbjct: 81 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS-QICKGMEYL-- 133
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 134 GTKRYI-HRDL 143
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSEVA-----LKRFKNCSAAGDATFKHEVEVIASVR 345
F + ++G G +G VYKGL +P+G +V ++ + S + E V+ASV
Sbjct: 50 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 110 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 157
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 158 VQIAKGMNYLE---DRRLVHRDLAA 179
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 19/139 (13%)
Query: 291 RNFSRDNIIGRGGYGNVY--KGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVN 348
+ F ++G G + V+ K L G ALK K A D++ ++E+ V+ ++H N
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 349 LVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFAS---NGPKLSWPLRQSIALGTAR 405
+V L +TT +V L+ G ++D + S ++Q ++
Sbjct: 68 IVTLEDIYESTTHY-----YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS----- 117
Query: 406 GLAYLHFGAQPAIFHRDIK 424
+ YLH + I HRD+K
Sbjct: 118 AVKYLH---ENGIVHRDLK 133
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 36 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ +
Sbjct: 96 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKF 149
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 150 L---ASKKFVHRDLAA 162
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 33 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ +
Sbjct: 93 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKF 146
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 147 L---ASKKFVHRDLAA 159
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 36 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ +
Sbjct: 96 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKF 149
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 150 L---ASKKFVHRDLAA 162
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ +
Sbjct: 95 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKF 148
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 149 L---ASKKFVHRDLAA 161
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++ G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 16 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 76 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 124 VQIAKGMNYLE---DRRLVHRDLAA 145
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ +
Sbjct: 95 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKF 148
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 149 L---ASKKFVHRDLAA 161
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 40 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ +
Sbjct: 100 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKF 153
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 154 L---ASKKFVHRDLAA 166
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++ G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 83 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 131 VQIAKGMNYLE---DRRLVHRDLAA 152
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 29/161 (18%)
Query: 282 TFDDIKKATR-NFSRDNIIGRGGYGNVYKGLL------PDGSEVALKRFKNCSAAGDA-T 333
+ D+K+ R N + +G G +G VY+G + P +VA+K + D
Sbjct: 35 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD 94
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW 393
F E +I+ H N+V CI + L+ R I+ +LM G + L + P+ S
Sbjct: 95 FLMEALIISKFNHQNIVR----CIGVS-LQSLPRFILLELMAGGDLKSFLRETR-PRPSQ 148
Query: 394 PLRQS------IALGTARGLAYL---HFGAQPAIFHRDIKA 425
P + +A A G YL HF HRDI A
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 183
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 296 DNIIGRGGYGNVYKGLL--PDGSEV--ALKRFKNCSAAGDAT-FKHEVEVIASVRHVNLV 350
+ +IGRG +G VY G L DG ++ A+K + G+ + F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF-ASNGPKLSWPLRQSIALGTARGLAY 409
+L G C+ + EG ++V MK+G + + + ++ P + + L A+G+ +
Sbjct: 154 SLLGICLRS---EG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKF 207
Query: 410 LHFGAQPAIFHRDIKA 425
L A HRD+ A
Sbjct: 208 L---ASKKFVHRDLAA 220
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 77 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 129
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 130 GTKRYI-HRDL 139
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 82 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 134
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 135 GTKRYI-HRDL 144
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 26/145 (17%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSE----VALKRFKNC-SAAGDATFKHEVEVIASVR 345
F + ++ G +G VYKGL +P+G + VA+K + S + E V+ASV
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN---GPK--LSWPLRQSIA 400
+ ++ L G C+ +T ++ LM G + D++ G + L+W
Sbjct: 83 NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 401 LGTARGLAYLHFGAQPAIFHRDIKA 425
+ A+G+ YL + HRD+ A
Sbjct: 131 VQIAKGMNYLE---DRRLVHRDLAA 152
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHL 383
G C + G + + ++ + + GS+ D+L
Sbjct: 109 GVCYSA----GRRNLKLIMEYLPYGSLRDYL 135
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 78 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 130
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 131 GTKRYI-HRDL 140
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 78 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 130
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 131 GTKRYI-HRDL 140
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL D + AS + PL +S +
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLSMDLK------DFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 118 GLAFCH---SHRVLHRDLK 133
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL D + AS + PL +S +
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLSMDLK------DFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 117 GLAFCH---SHRVLHRDLK 132
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHL 383
G C + G + + ++ + + GS+ D+L
Sbjct: 79 GVCYSA----GRRNLKLIMEYLPYGSLRDYL 105
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 76 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 128
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 129 GTKRYI-HRDL 138
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 84 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 136
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 137 GTKRYI-HRDL 146
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 81 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 133
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 134 GTKRYI-HRDL 143
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 78 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 130
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 131 GTKRYI-HRDL 140
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 83 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 135
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 136 GTKRYI-HRDL 145
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G VY L KLS Q A
Sbjct: 71 RHPNILRLYGYFHDATRV-----YLILEYAPRGEVYKEL-----QKLSKFDEQRTATYIT 120
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 121 ELANALSYCH---SKRVIHRDIK 140
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHL 383
G C + G + + ++ + + GS+ D+L
Sbjct: 85 GVCYSA----GRRNLKLIMEYLPYGSLRDYL 111
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ D+L L Q + +G+ YL
Sbjct: 96 GVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 148
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 149 GTKRYI-HRDL 158
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G VY L KLS Q A
Sbjct: 71 RHPNILRLYGYFHDATRV-----YLILEYAPRGEVYKEL-----QKLSKFDEQRTATYIT 120
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 121 ELANALSYCH---SKRVIHRDIK 140
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L +V + + + + D + AS + PL +S +
Sbjct: 61 HPNIVKLLDVIHTENKL-----YLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 115 GLAFCH---SHRVLHRDLK 130
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 39/138 (28%), Positives = 67/138 (48%), Gaps = 14/138 (10%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKHEVEVIASVRHVNLV 350
+++ +IG G +G VY+ L D E VA+K+ G A E++++ + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 351 ALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARGL 407
LR + ++ + + + +V D + +VY + K + P+ + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 408 AYLH-FGAQPAIFHRDIK 424
AY+H FG I HRDIK
Sbjct: 136 AYIHSFG----ICHRDIK 149
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 75
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 135 LAYIHSFG----ICHRDIK 149
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLSMDLKK------FMDASALTGIPLPLIKSYLFQLLQ 115
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 116 GLAFCH---SHRVLHRDLK 131
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 39/138 (28%), Positives = 67/138 (48%), Gaps = 14/138 (10%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKHEVEVIASVRHVNLV 350
+++ +IG G +G VY+ L D E VA+K+ G A E++++ + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 351 ALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARGL 407
LR + ++ + + + +V D + +VY + K + P+ + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 408 AYLH-FGAQPAIFHRDIK 424
AY+H FG I HRDIK
Sbjct: 136 AYIHSFG----ICHRDIK 149
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 39/138 (28%), Positives = 67/138 (48%), Gaps = 14/138 (10%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKHEVEVIASVRHVNLV 350
+++ +IG G +G VY+ L D E VA+K+ G A E++++ + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 351 ALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARGL 407
LR + ++ + + + +V D + +VY + K + P+ + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 408 AYLH-FGAQPAIFHRDIK 424
AY+H FG I HRDIK
Sbjct: 136 AYIHSFG----ICHRDIK 149
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHL 383
G C + G + + ++ + + GS+ D+L
Sbjct: 96 GVCYSA----GRRNLKLIMEYLPYGSLRDYL 122
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 39/128 (30%), Positives = 57/128 (44%), Gaps = 12/128 (9%)
Query: 299 IGRGGYGNVYKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCI 357
+G G YG+VYK + + G VA+K+ S + E+ ++ ++V G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII--KEISIMQQCDSPHVVKYYGSYF 94
Query: 358 ATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPA 417
T L IV + GSV D + N L+ +I T +GL YLHF +
Sbjct: 95 KNTDL-----WIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHFMRK-- 146
Query: 418 IFHRDIKA 425
HRDIKA
Sbjct: 147 -IHRDIKA 153
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 75
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 135 LAYIHSFG----ICHRDIK 149
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 76
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 77 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 136 LAYIHSFG----ICHRDIK 150
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 75
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 135 LAYIHSFG----ICHRDIK 149
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 88
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 89 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 148 LAYIHSFG----ICHRDIK 162
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLSMDLKK------FMDASALTGIPLPLIKSYLFQLLQ 117
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 118 GLAFCH---SHRVLHRDLK 133
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 94
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 95 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 154 LAYIHSFG----ICHRDIK 168
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 83
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 84 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 143 LAYIHSFG----ICHRDIK 157
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 36/129 (27%), Positives = 53/129 (41%), Gaps = 11/129 (8%)
Query: 299 IGRGGYGNVYKGLL-PDGSEVALKRFKNCSAAG-DATFKHEVEVIASVRHVNLVALRGYC 356
IGRG +G V+ G L D + VA+K + A F E ++ H N+V L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQP 416
+ IV +L++ G L + G +L + A G+ YL
Sbjct: 182 TQKQPI-----YIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 417 AIFHRDIKA 425
HRD+ A
Sbjct: 233 CCIHRDLAA 241
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 64/143 (44%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + + ALK + + A + + EVE+ + +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY +T++ ++ + G+VY L KLS Q A
Sbjct: 66 RHPNILRLYGYFHDSTRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 116 ELANALSYCH---SKKVIHRDIK 135
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 36/129 (27%), Positives = 53/129 (41%), Gaps = 11/129 (8%)
Query: 299 IGRGGYGNVYKGLL-PDGSEVALKRFKNCSAAG-DATFKHEVEVIASVRHVNLVALRGYC 356
IGRG +G V+ G L D + VA+K + A F E ++ H N+V L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQP 416
+ IV +L++ G L + G +L + A G+ YL
Sbjct: 182 TQKQPI-----YIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 417 AIFHRDIKA 425
HRD+ A
Sbjct: 233 CCIHRDLAA 241
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 103
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 163 LAYIHSFG----ICHRDIK 177
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 79
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 80 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 139 LAYIHSFG----ICHRDIK 153
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 87
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 88 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 147 LAYIHSFG----ICHRDIK 161
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 109
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 169 LAYIHSFG----ICHRDIK 183
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 87
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 88 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 147 LAYIHSFG----ICHRDIK 161
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 80
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 81 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 140 LAYIHSFG----ICHRDIK 154
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 111
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 171 LAYIHSFG----ICHRDIK 185
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 109
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 169 LAYIHSFG----ICHRDIK 183
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 35/145 (24%), Positives = 59/145 (40%), Gaps = 19/145 (13%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLP-DGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLV 350
+F +IG GG+G V+K DG +KR K + + EV+ +A + HVN+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67
Query: 351 ALRG------YCIATTQLEGHQRIIVC-----DLMKNGSVYDHLFASNGPKLSWPLRQSI 399
G Y T+ + C + G++ + G KL L +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 400 ALGTARGLAYLHFGAQPAIFHRDIK 424
+G+ Y+H + +RD+K
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLK 149
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 33/131 (25%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 299 IGRGGYGNV----YKGLLPD-GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALR 353
+G+G +G+V Y L + G VA+K+ ++ + F+ E+E++ S++H N+V +
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 354 GYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHF 412
G C + G + + ++ + + GS+ ++L L Q + +G+ YL
Sbjct: 81 GVCYSA----GRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS-QICKGMEYL-- 133
Query: 413 GAQPAIFHRDI 423
G + I HRD+
Sbjct: 134 GTKRYI-HRDL 143
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 113
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 173 LAYIHSFG----ICHRDIK 187
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 154
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 214 LAYIHSFG----ICHRDIK 228
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/161 (29%), Positives = 69/161 (42%), Gaps = 32/161 (19%)
Query: 292 NFSRDNI-----IGRGGYGNVYK----GLLP--DGSEVALKRFKN-CSAAGDATFKHEVE 339
+ R+NI IG G +G V++ GLLP + VA+K K SA A F+ E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 340 VIASVRHVNLVALRGYC------------IATTQLEGHQRII----VCDLMKNG-SVYDH 382
++A + N+V L G C +A L R + VC L + S
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 383 LFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDI 423
+ + P LS + IA A G+AYL ++ HRD+
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDL 200
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 83 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 132
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 133 ELANALSYCH---SKRVIHRDIK 152
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 92 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 141
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 142 ELANALSYCH---SKRVIHRDIK 161
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 92 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 141
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 142 ELANALSYCH---SKRVIHRDIK 161
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 68 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 117
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 118 ELANALSYCH---SKRVIHRDIK 137
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 69 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 119 ELANALSYCH---SKRVIHRDIK 138
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 68 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 117
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 118 ELANALSYCH---SKRVIHRDIK 137
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 115 GLAFCH---SHRVLHRDLK 130
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 66 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 116 ELANALSYCH---SKRVIHRDIK 135
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 67 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 116
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 117 ELANALSYCH---SKRVIHRDIK 136
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 67 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 116
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 117 ELANALSYCH---SKRVIHRDIK 136
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 66 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 116 ELANALSYCH---SKRVIHRDIK 135
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 71 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 120
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 121 ELANALSYCH---SKRVIHRDIK 140
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 67 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 116
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 117 ELANALSYCH---SKRVIHRDIK 136
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 66 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 116 ELANALSYCH---SKRVIHRDIK 135
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 66 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 116 ELANALSYCH---SKRVIHRDIK 135
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 71 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 120
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 121 ELANALSYCH---SKRVIHRDIK 140
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 115 GLAFCH---SHRVLHRDLK 130
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 69 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 119 ELANALSYCH---SKRVIHRDIK 138
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 115 GLAFCH---SHRVLHRDLK 130
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 115
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 116 GLAFCH---SHRVLHRDLK 131
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 116
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 117 GLAFCH---SHRVLHRDLK 132
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 69 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 119 ELANALSYCH---SKRVIHRDIK 138
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 65 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 118
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 119 GLAFCH---SHRVLHRDLK 134
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 114
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 115 GLAFCH---SHRVLHRDLK 130
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 71 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 120
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 121 ELANALSYCH---SKRVIHRDIK 140
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 43/143 (30%), Positives = 63/143 (44%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK-RFK-NCSAAG-DATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK FK AG + + EVE+ + +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 69 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 119 ELANALSYCH---SKRVIHRDIK 138
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 117
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 118 GLAFCH---SHRVLHRDLK 133
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 116
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 117 GLAFCH---SHRVLHRDLK 132
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 116
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 117 GLAFCH---SHRVLHRDLK 132
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 117 AFCH---SHRVLHRDLK 130
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 115
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 116 GLAFCH---SHRVLHRDLK 131
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 116 AFCH---SHRVLHRDLK 129
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 38.1 bits (87), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFKNCSAAGDATFKH-EVEVIASVRHVNL 349
+++ +IG G +G VY+ L D E VA+K+ D FK+ E++++ + H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNI 75
Query: 350 VALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWPL--RQSIALGTARG 406
V LR + ++ + + + +V D + +VY + K + P+ + R
Sbjct: 76 VRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 407 LAYLH-FGAQPAIFHRDIK 424
LAY+H FG I HRDIK
Sbjct: 135 LAYIHSFG----ICHRDIK 149
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 38.1 bits (87), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 115
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 116 GLAFCH---SHRVLHRDLK 131
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 38.1 bits (87), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 65 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 114
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 115 ELANALSYCH---SKRVIHRDIK 134
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 69 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 119 ELANALSYCH---SKRVIHRDIK 138
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 116 AFCH---SHRVLHRDLK 129
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 116 AFCH---SHRVLHRDLK 129
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 117
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 118 GLAFCH---SHRVLHRDLK 133
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 124 AFCH---SHRVLHRDLK 137
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 66 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 116 ELANALSYCH---SKRVIHRDIK 135
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 116 AFCH---SHRVLHRDLK 129
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 40/142 (28%), Positives = 60/142 (42%), Gaps = 10/142 (7%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEV---IA 342
AT + IG G YG VYK P G VALK R N + EV + +
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 343 SVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALG 402
+ H N+V L C AT++ + ++ + + + +L + P L + +
Sbjct: 62 AFEHPNVVRLMDVC-ATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 403 TARGLAYLHFGAQPAIFHRDIK 424
RGL +LH I HRD+K
Sbjct: 121 FLRGLDFLHAN---CIVHRDLK 139
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 66 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 116 ELANALSYCH---SKRVIHRDIK 135
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 70 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 119
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 120 ELANALSYCH---SKRVIHRDIK 139
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 40/142 (28%), Positives = 60/142 (42%), Gaps = 10/142 (7%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEV---IA 342
AT + IG G YG VYK P G VALK R N + EV + +
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 343 SVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALG 402
+ H N+V L C AT++ + ++ + + + +L + P L + +
Sbjct: 62 AFEHPNVVRLMDVC-ATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 403 TARGLAYLHFGAQPAIFHRDIK 424
RGL +LH I HRD+K
Sbjct: 121 FLRGLDFLHAN---CIVHRDLK 139
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 117 AFCH---SHRVLHRDLK 130
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 117 AFCH---SHRVLHRDLK 130
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 69 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 119 ELANALSYCH---SKRVIHRDIK 138
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 66 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 116 ELANALSYCH---SKRVIHRDIK 135
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 40/142 (28%), Positives = 60/142 (42%), Gaps = 10/142 (7%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEV---IA 342
AT + IG G YG VYK P G VALK R N + EV + +
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 343 SVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALG 402
+ H N+V L C AT++ + ++ + + + +L + P L + +
Sbjct: 62 AFEHPNVVRLMDVC-ATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 403 TARGLAYLHFGAQPAIFHRDIK 424
RGL +LH I HRD+K
Sbjct: 121 FLRGLDFLHAN---CIVHRDLK 139
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 37.7 bits (86), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 23/160 (14%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-AT 333
F D+ + A + +G+G +G VY KG++ D E VA+K ++ +
Sbjct: 6 FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNG 388
F +E V+ ++V L G +G +++ +LM G + +L + N
Sbjct: 66 FLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENN 120
Query: 389 PKLSWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
P L+ P L + I + A G+AYL+ HRD+ A
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 157
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 37.7 bits (86), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 124 AFCH---SHRVLHRDLK 137
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 37.7 bits (86), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 39/136 (28%), Positives = 56/136 (41%), Gaps = 12/136 (8%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHVN 348
NF + IG G YG VYK G VALK R + +T E+ ++ + H N
Sbjct: 8 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 349 LVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLA 408
+V L +L + DL K + AS + PL +S +GLA
Sbjct: 68 IVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 409 YLHFGAQPAIFHRDIK 424
+ H + HRD+K
Sbjct: 122 FCH---SHRVLHRDLK 134
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 37/144 (25%)
Query: 297 NIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKH-EVEVIASVRHVNLVALRGY 355
+IG G +G V++ L + EVA+K+ D FK+ E++++ V+H N+V L+ +
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKK-----VLQDKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 356 CIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSW-------PLRQSIAL------- 401
+ K V+ +L P+ + L+Q++ +
Sbjct: 101 FYSNGD-------------KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 402 -GTARGLAYLHFGAQPAIFHRDIK 424
R LAY+H I HRDIK
Sbjct: 148 YQLLRSLAYIH---SIGICHRDIK 168
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 39/137 (28%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 118 AFCH---SHRVLHRDLK 131
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK---RFKNCSAAGDATFKHEVEVIASV 344
A +F +G+G +GNVY + ALK + + A + + EVE+ + +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 345 RHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---L 401
RH N++ L GY T++ ++ + G+VY L KLS Q A
Sbjct: 63 RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 112
Query: 402 GTARGLAYLHFGAQPAIFHRDIK 424
A L+Y H + HRDIK
Sbjct: 113 ELANALSYCH---SKRVIHRDIK 132
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L + E ++ L ++ + A G + PL +S +
Sbjct: 64 HPNIVKL----LDVIHTENKLYLVFEFLHQDLKTFMDASALTG--IPLPLIKSYLFQLLQ 117
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 118 GLAFCH---SHRVLHRDLK 133
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 37/137 (27%), Positives = 55/137 (40%), Gaps = 10/137 (7%)
Query: 292 NFSRDNIIGRGGYGNVYKGL-LPDGSEVALKR---FKNCSAAGDATFKHEVEVIASVRHV 347
NF + IGRG + VY+ L DG VALK+ F A A E++++ + H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N++ I +L IV +L G + + K P R
Sbjct: 93 NVIKYYASFIEDNELN-----IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 408 AYLHFGAQPAIFHRDIK 424
A H ++ + HRDIK
Sbjct: 148 ALEHMHSR-RVMHRDIK 163
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 18/139 (12%)
Query: 297 NIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIAS--VRHVNLVALRG 354
I RG +G V+K L + VA+K F +++ E E+ ++ ++H NL+
Sbjct: 21 EIKARGRFGCVWKAQLMNDF-VAVKIF---PLQDKQSWQSEREIFSTPGMKHENLLQFIA 76
Query: 355 YCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLH--- 411
+ LE +I GS+ D+L G ++W +A +RGL+YLH
Sbjct: 77 AEKRGSNLEVELWLITA-FHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDV 132
Query: 412 -----FGAQPAIFHRDIKA 425
G +P+I HRD K+
Sbjct: 133 PWCRGEGHKPSIAHRDFKS 151
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 36/137 (26%), Positives = 57/137 (41%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L + E ++ + ++ + A G + PL +S +GL
Sbjct: 62 NIVKL----LDVIHTENKLYLVFEHVHQDLKTFMDASALTG--IPLPLIKSYLFQLLQGL 115
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 116 AFCH---SHRVLHRDLK 129
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
+ NF + IG G YG VYK G VALK R + +T E+ ++ +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 346 HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR 405
H N+V L +L + DL K + AS + PL +S +
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEHVDQDLKK------FMDASALTGIPLPLIKSYLFQLLQ 117
Query: 406 GLAYLHFGAQPAIFHRDIK 424
GLA+ H + HRD+K
Sbjct: 118 GLAFCH---SHRVLHRDLK 133
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-AT 333
+ D+ + A + +G+G +G VY KG++ D E VA+K ++ +
Sbjct: 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNG 388
F +E V+ ++V L G +G +++ +LM G + +L + +N
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 389 PKLSWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
P L+ P L + I + A G+AYL+ HRD+ A
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 37.0 bits (84), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 23/160 (14%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-AT 333
+ D+ + A + +G+G +G VY KG++ D E VA+K ++ +
Sbjct: 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNG 388
F +E V+ ++V L G +G +++ +LM G + +L + N
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENN 129
Query: 389 PKLSWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
P L+ P L + I + A G+AYL+ HRD+ A
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VALK R + +T E+ ++ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 408 AYLHFGAQPAIFHRDIK 424
++ H + HRD+K
Sbjct: 117 SFCH---SHRVLHRDLK 130
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-AT 333
+ D+ + A + +G+G +G VY KG++ D E VA+K ++ +
Sbjct: 5 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNG 388
F +E V+ ++V L G +G +++ +LM G + +L + +N
Sbjct: 65 FLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANN 119
Query: 389 PKLSWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
P L+ P L + I + A G+AYL+ HRD+ A
Sbjct: 120 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 156
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 23/160 (14%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-AT 333
+ D+ + A + +G+G +G VY KG++ D E VA+K ++ +
Sbjct: 8 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNG 388
F +E V+ ++V L G +G +++ +LM G + +L + N
Sbjct: 68 FLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 389 PKLSWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
P L+ P L + I + A G+AYL+ HRD+ A
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 159
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 36.6 bits (83), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 284 DDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-ATFKH 336
D+ + A + +G+G +G VY KG++ D E VA+K ++ + F +
Sbjct: 3 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 337 EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNGPKL 391
E V+ ++V L G +G +++ +LM G + +L + N P L
Sbjct: 63 EASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 117
Query: 392 SWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
+ P L + I + A G+AYL+ HRD+ A
Sbjct: 118 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 151
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 284 DDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-ATFKH 336
D+ + A + +G+G +G VY KG++ D E VA+K ++ + F +
Sbjct: 12 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 337 EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNGPKL 391
E V+ ++V L G +G +++ +LM G + +L + N P L
Sbjct: 72 EASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 392 SWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
+ P L + I + A G+AYL+ HRD+ A
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 160
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 23/160 (14%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-AT 333
+ D+ + A + +G+G +G VY KG++ D E VA+K ++ +
Sbjct: 2 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNG 388
F +E V+ ++V L G +G +++ +LM G + +L + N
Sbjct: 62 FLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENN 116
Query: 389 PKLSWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
P L+ P L + I + A G+AYL+ HRD+ A
Sbjct: 117 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 153
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 23/160 (14%)
Query: 281 FTFDDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-AT 333
+ D+ + A + +G+G +G VY KG++ D E VA+K ++ +
Sbjct: 8 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 334 FKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNG 388
F +E V+ ++V L G +G +++ +LM G + +L + N
Sbjct: 68 FLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 389 PKLSWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
P L+ P L + I + A G+AYL+ HRD+ A
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 159
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 36/135 (26%), Positives = 59/135 (43%), Gaps = 13/135 (9%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNC--SAAGDATFKHEVEVIASVRHVNLV 350
F++ + IG+G +G VYKG+ EV + + + + E+ V++ +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
G + +T+L I+ + + GS D L GP L +I +GL YL
Sbjct: 81 RYFGSYLKSTKL-----WIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYL 132
Query: 411 HFGAQPAIFHRDIKA 425
H + HRDIKA
Sbjct: 133 HSERK---IHRDIKA 144
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 20/140 (14%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK-RFKNC--SAAGDATFKHEVEVIASVRHV 347
+F +G+G +GNVY + ALK FK A + + EVE+ + +RH
Sbjct: 13 DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---LGTA 404
N++ L GY T++ ++ + G+VY L KLS Q A A
Sbjct: 73 NILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELA 122
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
L+Y H + HRDIK
Sbjct: 123 NALSYCH---SKRVIHRDIK 139
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 284 DDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-ATFKH 336
D+ + A + +G+G +G VY KG++ D E VA+K ++ + F +
Sbjct: 5 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 337 EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNGPKL 391
E V+ ++V L G +G +++ +LM G + +L + N P L
Sbjct: 65 EASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 392 SWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
+ P L + I + A G+AYL+ HRD+ A
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 153
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 284 DDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-ATFKH 336
D+ + A + +G+G +G VY KG++ D E VA+K ++ + F +
Sbjct: 12 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 337 EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNGPKL 391
E V+ ++V L G +G +++ +LM G + +L + N P L
Sbjct: 72 EASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 392 SWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
+ P L + I + A G+AYL+ HRD+ A
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 160
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 36.2 bits (82), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 20/140 (14%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK-RFKNC--SAAGDATFKHEVEVIASVRHV 347
+F +G+G +GNVY + ALK FK A + + EVE+ + +RH
Sbjct: 13 DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA---LGTA 404
N++ L GY T++ ++ + G+VY L KLS Q A A
Sbjct: 73 NILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELA 122
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
L+Y H + HRDIK
Sbjct: 123 NALSYCH---SKRVIHRDIK 139
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 36.2 bits (82), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 36/142 (25%), Positives = 59/142 (41%), Gaps = 17/142 (11%)
Query: 288 KATRNFSRDNIIGRGGYGNVYKGLLPD-GSEVALKRFKNCSAAGDATFK----HEVEVIA 342
++ + ++G G YG V K D G VA+K+F + D K E++++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLK 79
Query: 343 SVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALG 402
+RH NLV L C + +V + + + + D NG L + + Q
Sbjct: 80 QLRHENLVNLLEVCKKKKRW-----YLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQ 132
Query: 403 TARGLAYLHFGAQPAIFHRDIK 424
G+ + H I HRDIK
Sbjct: 133 IINGIGFCH---SHNIIHRDIK 151
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 36.2 bits (82), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 60/145 (41%), Gaps = 13/145 (8%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVR 345
AT + IG G YG VYK P G VALK R N G V +A +R
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 346 ------HVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSI 399
H N+V L C AT++ + ++ + + + +L + P L + +
Sbjct: 67 RLEAFEHPNVVRLMDVC-ATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 400 ALGTARGLAYLHFGAQPAIFHRDIK 424
RGL +LH I HRD+K
Sbjct: 126 MRQFLRGLDFLHAN---CIVHRDLK 147
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 36.2 bits (82), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 40/171 (23%), Positives = 66/171 (38%), Gaps = 34/171 (19%)
Query: 279 VRFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLP-DGSEVALKRFKNCSAAGDATFKHE 337
++T D K+ +F +IG GG+G V+K DG ++R K + + E
Sbjct: 2 TKYTVD--KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----RE 55
Query: 338 VEVIASVRHVNLVALRG------YCIATTQ--LEGHQR----------------IIVCDL 373
V+ +A + HVN+V G Y T+ LE I +
Sbjct: 56 VKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEF 115
Query: 374 MKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIK 424
G++ + G KL L + +G+ Y+H + HRD+K
Sbjct: 116 CDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLK 163
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 284 DDIKKATRNFSRDNIIGRGGYGNVY----KGLLPDGSE--VALKRFKNCSAAGD-ATFKH 336
D+ + A + +G+G +G VY KG++ D E VA+K ++ + F +
Sbjct: 40 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 337 EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA-----SNGPKL 391
E V+ ++V L G +G +++ +LM G + +L + N P L
Sbjct: 100 EASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 154
Query: 392 SWP-LRQSIALG--TARGLAYLHFGAQPAIFHRDIKA 425
+ P L + I + A G+AYL+ HRD+ A
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 188
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 35.8 bits (81), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 33/134 (24%), Positives = 59/134 (44%), Gaps = 13/134 (9%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEV--ALKRFKNCSAAGDATFKHEVEVIASVRHVNLV 350
++ +N IGRG +G V K + G+ + A K+ FK E+E++ S+ H N++
Sbjct: 28 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
L T + +V +L G +++ + + S R I +AY
Sbjct: 87 RLYETFEDNTDI-----YLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYC 139
Query: 411 HFGAQPAIFHRDIK 424
H + + HRD+K
Sbjct: 140 H---KLNVAHRDLK 150
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 35.8 bits (81), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 55/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VAL R + +T E+ ++ + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 117 AFCH---SHRVLHRDLK 130
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 35.8 bits (81), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 38/137 (27%), Positives = 55/137 (40%), Gaps = 12/137 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLP-DGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHV 347
NF + IG G YG VYK G VAL R + +T E+ ++ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGL 407
N+V L +L + DL K + AS + PL +S +GL
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 408 AYLHFGAQPAIFHRDIK 424
A+ H + HRD+K
Sbjct: 116 AFCH---SHRVLHRDLK 129
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 35.8 bits (81), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 33/134 (24%), Positives = 59/134 (44%), Gaps = 13/134 (9%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEV--ALKRFKNCSAAGDATFKHEVEVIASVRHVNLV 350
++ +N IGRG +G V K + G+ + A K+ FK E+E++ S+ H N++
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
L T + +V +L G +++ + + S R I +AY
Sbjct: 70 RLYETFEDNTDI-----YLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYC 122
Query: 411 HFGAQPAIFHRDIK 424
H + + HRD+K
Sbjct: 123 H---KLNVAHRDLK 133
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 35/128 (27%), Positives = 55/128 (42%), Gaps = 12/128 (9%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYC 356
IG G YG VYK G ALK R + +T E+ ++ ++H N+V L Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQP 416
+ T+ +R+++ + + L G L +S L G+AY H
Sbjct: 68 VIHTK----KRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 417 AIFHRDIK 424
+ HRD+K
Sbjct: 120 RVLHRDLK 127
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 36/137 (26%), Positives = 60/137 (43%), Gaps = 17/137 (12%)
Query: 296 DNIIGRGGYGNVYKGLLPDGS----EVALKRFKNCSAAGDA-TFKHEVEVIASVRHVNLV 350
D +IG+G +G VY G D + + A+K + F E ++ + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALG--TARGLA 408
AL G + L ++ M +G D L P+ + ++ I+ G ARG+
Sbjct: 86 ALIGIMLPPEGLPH----VLLPYMCHG---DLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 409 YLHFGAQPAIFHRDIKA 425
YL A+ HRD+ A
Sbjct: 139 YL---AEQKFVHRDLAA 152
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 35/128 (27%), Positives = 55/128 (42%), Gaps = 12/128 (9%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYC 356
IG G YG VYK G ALK R + +T E+ ++ ++H N+V L Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQP 416
+ T+ +R+++ + + L G L +S L G+AY H
Sbjct: 68 VIHTK----KRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 417 AIFHRDIK 424
+ HRD+K
Sbjct: 120 RVLHRDLK 127
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/128 (27%), Positives = 55/128 (42%), Gaps = 12/128 (9%)
Query: 299 IGRGGYGNVYKGLLPDGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYC 356
IG G YG VYK G ALK R + +T E+ ++ ++H N+V L Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQP 416
+ T+ +R+++ + + L G L +S L G+AY H
Sbjct: 68 VIHTK----KRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 417 AIFHRDIK 424
+ HRD+K
Sbjct: 120 RVLHRDLK 127
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 36/136 (26%), Positives = 55/136 (40%), Gaps = 12/136 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFK-NCSAAG-DATFKHEVEVIASVRHVN 348
+ + +G G YG VYK G VALKR + + G +T E+ ++ + H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 349 LVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLA 408
+V+L + L + DL K + N L + RG+A
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKK-------VLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 409 YLHFGAQPAIFHRDIK 424
+ H Q I HRD+K
Sbjct: 134 HCH---QHRILHRDLK 146
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 31/145 (21%), Positives = 57/145 (39%), Gaps = 22/145 (15%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDAT-----------FKHEVEVI 341
++ I G YG V G+ +G VA+KR N + G E+ ++
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNG---SVYDHLFASNGPKLSWPLRQS 398
H N++ LR + + H+ +V +LM+ ++D + + + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH- 142
Query: 399 IALGTARGLAYLHFGAQPAIFHRDI 423
I LG LH + + HRD+
Sbjct: 143 ILLG-------LHVLHEAGVVHRDL 160
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 34.3 bits (77), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 36/136 (26%), Positives = 55/136 (40%), Gaps = 12/136 (8%)
Query: 291 RNFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFK-NCSAAG-DATFKHEVEVIASVRHVN 348
+ + +G G YG VYK G VALKR + + G +T E+ ++ + H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 349 LVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLA 408
+V+L + L + DL K + N L + RG+A
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKK-------VLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 409 YLHFGAQPAIFHRDIK 424
+ H Q I HRD+K
Sbjct: 134 HCH---QHRILHRDLK 146
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 31/145 (21%), Positives = 57/145 (39%), Gaps = 22/145 (15%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDAT-----------FKHEVEVI 341
++ I G YG V G+ +G VA+KR N + G E+ ++
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNG---SVYDHLFASNGPKLSWPLRQS 398
H N++ LR + + H+ +V +LM+ ++D + + + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH- 142
Query: 399 IALGTARGLAYLHFGAQPAIFHRDI 423
I LG LH + + HRD+
Sbjct: 143 ILLG-------LHVLHEAGVVHRDL 160
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 34/140 (24%), Positives = 57/140 (40%), Gaps = 15/140 (10%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGS----EVALKR-FKNCSAAGDATFKHEVEVIAS 343
A + + I+G G +G VY+G+ + VA+K K+C+ F E ++ +
Sbjct: 6 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 344 VRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGT 403
+ H ++V L G +E I+ +L G + H N L +L
Sbjct: 66 LDHPHIVKLIGI------IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQI 118
Query: 404 ARGLAYLHFGAQPAIFHRDI 423
+ +AYL HRDI
Sbjct: 119 CKAMAYLE---SINCVHRDI 135
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 33.5 bits (75), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 34/140 (24%), Positives = 57/140 (40%), Gaps = 15/140 (10%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGS----EVALKR-FKNCSAAGDATFKHEVEVIAS 343
A + + I+G G +G VY+G+ + VA+K K+C+ F E ++ +
Sbjct: 22 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 344 VRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGT 403
+ H ++V L G +E I+ +L G + H N L +L
Sbjct: 82 LDHPHIVKLIGI------IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQI 134
Query: 404 ARGLAYLHFGAQPAIFHRDI 423
+ +AYL HRDI
Sbjct: 135 CKAMAYLE---SINCVHRDI 151
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 34/140 (24%), Positives = 57/140 (40%), Gaps = 15/140 (10%)
Query: 289 ATRNFSRDNIIGRGGYGNVYKGLLPDGS----EVALKR-FKNCSAAGDATFKHEVEVIAS 343
A + + I+G G +G VY+G+ + VA+K K+C+ F E ++ +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 344 VRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGT 403
+ H ++V L G +E I+ +L G + H N L +L
Sbjct: 70 LDHPHIVKLIGI------IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQI 122
Query: 404 ARGLAYLHFGAQPAIFHRDI 423
+ +AYL HRDI
Sbjct: 123 CKAMAYLE---SINCVHRDI 139
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 33.1 bits (74), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 55/132 (41%), Gaps = 14/132 (10%)
Query: 298 IIGRGGYGNVYKGL-LPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYC 356
++G+G YG VY G L + +A+K + E+ + ++H N+V G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR---GLAYLHFG 413
++ I + + GS+ L + GP Q+I T + GL YLH
Sbjct: 89 SENGFIK-----IFMEQVPGGSLSALLRSKWGPLKDN--EQTIGFYTKQILEGLKYLH-- 139
Query: 414 AQPAIFHRDIKA 425
I HRDIK
Sbjct: 140 -DNQIVHRDIKG 150
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 33.1 bits (74), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 18/136 (13%)
Query: 292 NFSRDNIIGRGGYGN-VYKGLLPDGSEVALKR-FKNCSAAGDATFKHEVEVI-ASVRHVN 348
+F +++G G G VY+G+ D +VA+KR C + D EV+++ S H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFAD----REVQLLRESDEHPN 79
Query: 349 LVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLA 408
++ R +C + + I +C V FA G + L+Q T GLA
Sbjct: 80 VI--RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQ-----TTSGLA 132
Query: 409 YLHFGAQPAIFHRDIK 424
+LH I HRD+K
Sbjct: 133 HLH---SLNIVHRDLK 145
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 33.1 bits (74), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 55/132 (41%), Gaps = 14/132 (10%)
Query: 298 IIGRGGYGNVYKGL-LPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYC 356
++G+G YG VY G L + +A+K + E+ + ++H N+V G
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 357 IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTAR---GLAYLHFG 413
++ I + + GS+ L + GP Q+I T + GL YLH
Sbjct: 75 SENGFIK-----IFMEQVPGGSLSALLRSKWGPLKDN--EQTIGFYTKQILEGLKYLH-- 125
Query: 414 AQPAIFHRDIKA 425
I HRDIK
Sbjct: 126 -DNQIVHRDIKG 136
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 33.1 bits (74), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 55/134 (41%), Gaps = 13/134 (9%)
Query: 299 IGRGGYGNVYKG--LLPDGSEVALKRFKNCSAAGDATFKHEVEV-----IASVRHVNLVA 351
IG G YG V+K L G VALKR + + EV + + H N+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 352 LRGYC-IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
L C ++ T E ++ + ++ + Y L P + + + RGL +L
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 411 HFGAQPAIFHRDIK 424
H + HRD+K
Sbjct: 137 H---SHRVVHRDLK 147
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 32.7 bits (73), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 33/146 (22%)
Query: 293 FSRDNIIGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEV 340
+++ IG G YG V Y + + VA+K+ + F+H E+++
Sbjct: 45 YTQLQYIGEGAYGMVSSAYDHV--RKTRVAIKKI--------SPFEHQTYCQRTLREIQI 94
Query: 341 IASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFAS--NGPKLSWPLRQS 398
+ RH N++ +R A+T IV DLM+ +Y L + + + + L Q
Sbjct: 95 LLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQLSNDHICYFLYQI 153
Query: 399 IALGTARGLAYLHFGAQPAIFHRDIK 424
+ RGL Y+H + HRD+K
Sbjct: 154 L-----RGLKYIHSA---NVLHRDLK 171
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 32.7 bits (73), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 55/134 (41%), Gaps = 13/134 (9%)
Query: 299 IGRGGYGNVYKG--LLPDGSEVALKRFKNCSAAGDATFKHEVEV-----IASVRHVNLVA 351
IG G YG V+K L G VALKR + + EV + + H N+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 352 LRGYC-IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
L C ++ T E ++ + ++ + Y L P + + + RGL +L
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 411 HFGAQPAIFHRDIK 424
H + HRD+K
Sbjct: 137 H---SHRVVHRDLK 147
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 32.3 bits (72), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 34/139 (24%), Positives = 63/139 (45%), Gaps = 21/139 (15%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNC--SAAGDATFKHEVEVIASVRHVNLV 350
F++ IG+G +G V+KG+ +V + + + + E+ V++ +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGP----KLSWPLRQSIALGTARG 406
G + L+G + I+ + + GS D L A GP +++ L++ + +G
Sbjct: 85 KYYG-----SYLKGSKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEIL-----KG 132
Query: 407 LAYLHFGAQPAIFHRDIKA 425
L YLH + HRDIKA
Sbjct: 133 LDYLHSEKK---IHRDIKA 148
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 55/134 (41%), Gaps = 13/134 (9%)
Query: 299 IGRGGYGNVYKG--LLPDGSEVALKRFKNCSAAGDATFKHEVEV-----IASVRHVNLVA 351
IG G YG V+K L G VALKR + + EV + + H N+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 352 LRGYC-IATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
L C ++ T E ++ + ++ + Y L P + + + RGL +L
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 411 HFGAQPAIFHRDIK 424
H + HRD+K
Sbjct: 137 H---SHRVVHRDLK 147
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 32.3 bits (72), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNC--SAAGDATFKHEVEVIASVRHVNLV 350
F++ IG+G +G V+KG+ +V + + + + E+ V++ +
Sbjct: 29 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
G + T+L I+ + + GS D L GP L +I +GL YL
Sbjct: 89 KYYGSYLKDTKL-----WIIMEYLGGGSALDLL--EPGP-LDETQIATILREILKGLDYL 140
Query: 411 HFGAQPAIFHRDIKA 425
H + HRDIKA
Sbjct: 141 HSEKK---IHRDIKA 152
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 32.3 bits (72), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 29/150 (19%)
Query: 288 KATRNFSRDNIIGRGGYGNVYKGLL----PDGSEVALKRFK--NCSAAGDATFKHEVEVI 341
++ + R IG G +G K +L DG + +K S+ + EV V+
Sbjct: 21 QSMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNG------PKLSWPL 395
A+++H N+V R + E IV D + G ++ + A G L W +
Sbjct: 78 ANMKHPNIVQYR-----ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 396 RQSIALGTARGLAYLHFGAQPAIFHRDIKA 425
+ +A L ++H I HRDIK+
Sbjct: 133 QICLA------LKHVH---DRKILHRDIKS 153
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 34/142 (23%), Positives = 62/142 (43%), Gaps = 13/142 (9%)
Query: 286 IKKATRNFSRDNIIGRGGYGNVYKGL-LPDGSEVALKRF--KNCSAAGDAT-FKHEVEVI 341
I + +F N++G+G + VY+ + G EVA+K K AG ++EV++
Sbjct: 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 342 ASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIAL 401
++H +++ L Y + + +V ++ NG + +L P S +
Sbjct: 66 CQLKHPSILELYNYFEDSNYV-----YLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMH 119
Query: 402 GTARGLAYLHFGAQPAIFHRDI 423
G+ YLH I HRD+
Sbjct: 120 QIITGMLYLH---SHGILHRDL 138
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 16/115 (13%)
Query: 315 GSEVALKRFKN-CSAAGDATFKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRI-IVCD 372
G VA+K K C + ++ E+E++ ++ H ++V +G C + +G + + +V +
Sbjct: 38 GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCC----EDQGEKSVQLVME 93
Query: 373 LMKNGSVYDHLFASNGPKLSWPLRQSI--ALGTARGLAYLHFGAQPAIFHRDIKA 425
+ GS+ D+L P+ L Q + A G+AYLH AQ I HR + A
Sbjct: 94 YVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLH--AQHYI-HRALAA 140
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 32.3 bits (72), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 16/115 (13%)
Query: 315 GSEVALKRFKN-CSAAGDATFKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRI-IVCD 372
G VA+K K C + ++ E+E++ ++ H ++V +G C + +G + + +V +
Sbjct: 37 GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCC----EDQGEKSVQLVME 92
Query: 373 LMKNGSVYDHLFASNGPKLSWPLRQSI--ALGTARGLAYLHFGAQPAIFHRDIKA 425
+ GS+ D+L P+ L Q + A G+AYLH AQ I HR + A
Sbjct: 93 YVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLH--AQHYI-HRALAA 139
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 32.0 bits (71), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNC--SAAGDATFKHEVEVIASVRHVNLV 350
F++ IG+G +G V+KG+ +V + + + + E+ V++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
G + T+L I+ + + GS D L GP L +I +GL YL
Sbjct: 69 KYYGSYLKDTKL-----WIIMEYLGGGSALDLL--EPGP-LDETQIATILREILKGLDYL 120
Query: 411 HFGAQPAIFHRDIKA 425
H + HRDIKA
Sbjct: 121 HSEKK---IHRDIKA 132
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 32.0 bits (71), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNC--SAAGDATFKHEVEVIASVRHVNLV 350
F++ IG+G +G V+KG+ +V + + + + E+ V++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
G + T+L I+ + + GS D L GP L +I +GL YL
Sbjct: 69 KYYGSYLKDTKL-----WIIMEYLGGGSALDLL--EPGP-LDETQIATILREILKGLDYL 120
Query: 411 HFGAQPAIFHRDIKA 425
H + HRDIKA
Sbjct: 121 HSEKK---IHRDIKA 132
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 32.0 bits (71), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNC--SAAGDATFKHEVEVIASVRHVNLV 350
F++ IG+G +G V+KG+ +V + + + + E+ V++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYL 410
G + T+L I+ + + GS D L GP L +I +GL YL
Sbjct: 84 KYYGSYLKDTKL-----WIIMEYLGGGSALDLL--EPGP-LDETQIATILREILKGLDYL 135
Query: 411 HFGAQPAIFHRDIKA 425
H + HRDIKA
Sbjct: 136 HSEKK---IHRDIKA 147
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 31.6 bits (70), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 16/98 (16%)
Query: 265 IEMGLESIHESTNLVRFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLL--PDGSE----V 318
+EM L + H+ L + ++ F + +G +G VYKG L P E V
Sbjct: 7 MEMPLINQHKQAKLKEISLSAVR-----FMEE--LGEDRFGKVYKGHLFGPAPGEQTQAV 59
Query: 319 ALKRFKNCSAAGD--ATFKHEVEVIASVRHVNLVALRG 354
A+K K+ A G F+HE + A ++H N+V L G
Sbjct: 60 AIKTLKD-KAEGPLREEFRHEAMLRARLQHPNVVCLLG 96
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 31.6 bits (70), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 37/135 (27%), Positives = 58/135 (42%), Gaps = 23/135 (17%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH----EVEVIASVRHVNLVA 351
IG G YG V Y L + VA+K+ S T+ E++++ RH N++
Sbjct: 35 IGEGAYGMVCSAYDNL--NKVRVAIKKI---SPFEHQTYXQRTLREIKILLRFRHENIIG 89
Query: 352 LRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTARGLAY 409
+ A T + IV DLM+ +Y L + + + L Q + RGL Y
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL-----RGLKY 143
Query: 410 LHFGAQPAIFHRDIK 424
+H + HRD+K
Sbjct: 144 IHSA---NVLHRDLK 155
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 31.6 bits (70), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 293 FSRDNIIGRGGYGNVYKGLLPDGSE-VALKRFK--NCSAAGDATFKHEVEVIASVRHVNL 349
+ R +G G YG VYK + +E VA+KR + + T EV ++ ++H N+
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 350 VALR 353
+ L+
Sbjct: 96 IELK 99
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 31.6 bits (70), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 29 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 78
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 79 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 132
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 133 RGLKYIHSA---NVLHRDLK 149
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 31.6 bits (70), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 36 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 85
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 86 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 139
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 140 RGLKYIHSA---NVLHRDLK 156
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 31.6 bits (70), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 37 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 86
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 87 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 140
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 141 RGLKYIHSA---NVLHRDLK 157
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 31.6 bits (70), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 28 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 77
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 78 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 131
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 132 RGLKYIHSA---NVLHRDLK 148
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 31.6 bits (70), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 35 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 138
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 139 RGLKYIHSA---NVLHRDLK 155
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 31.6 bits (70), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 31/134 (23%), Positives = 57/134 (42%), Gaps = 14/134 (10%)
Query: 294 SRDNIIGRGGYGNVYK-GLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVAL 352
S+ I+G G +G V+K G ++A K K K+E+ V+ + H NL+ L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 353 RGYCIATTQLEGHQRIIVCDLMKNGSVYDHLF--ASNGPKLSWPLRQSIALGTARGLAYL 410
+ + ++V + + G ++D + + N +L L G+ ++
Sbjct: 152 YDAFESKNDI-----VLVMEYVDGGELFDRIIDESYNLTELDTIL---FMKQICEGIRHM 203
Query: 411 HFGAQPAIFHRDIK 424
H Q I H D+K
Sbjct: 204 H---QMYILHLDLK 214
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 31.6 bits (70), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 35 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 138
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 139 RGLKYIHSA---NVLHRDLK 155
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 31.6 bits (70), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 35 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 138
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 139 RGLKYIHSA---NVLHRDLK 155
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 31.6 bits (70), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 36 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 85
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 86 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 139
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 140 RGLKYIHSA---NVLHRDLK 156
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 31.6 bits (70), Expect = 0.97, Method: Compositional matrix adjust.
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y L + VA+K+ + F+H E++++ RH
Sbjct: 29 IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 78
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 79 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 132
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 133 RGLKYIHSA---NVLHRDLK 149
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 31.6 bits (70), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 305 GNVYKGLLPDGSEVALK--RFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIATTQL 362
G ++KG G+++ +K + ++ S F E + H N++ + G C +
Sbjct: 24 GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP-- 80
Query: 363 EGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLH 411
++ M GS+Y+ L + AL ARG+A+LH
Sbjct: 81 -APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
>pdb|3ZZM|A Chain A, Crystal Structure Of Mycobacterium Tuberculosis Purh With
A Novel Bound Nucleotide Cfair, At 2.2 A Resolution.
pdb|3ZZM|B Chain B, Crystal Structure Of Mycobacterium Tuberculosis Purh With
A Novel Bound Nucleotide Cfair, At 2.2 A Resolution.
pdb|4A1O|A Chain A, Crystal Structure Of Mycobacterium Tuberculosis Purh
Complexed With Aicar And A Novel Nucleotide Cfair, At
2.48 A Resolution.
pdb|4A1O|B Chain B, Crystal Structure Of Mycobacterium Tuberculosis Purh
Complexed With Aicar And A Novel Nucleotide Cfair, At
2.48 A Resolution
Length = 523
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 9/75 (12%)
Query: 315 GSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNL--VALRGYCIATTQLEGHQRIIVCD 372
G +++ F + AA A F HE +A ++H N +A+ +A + H+ CD
Sbjct: 253 GKDMSYNNFTDADAAWRAAFDHEQTCVAIIKHANPCGIAISSVSVADAHRKAHE----CD 308
Query: 373 LMKNGSVYDHLFASN 387
+ S Y + A+N
Sbjct: 309 PL---SAYGGVIAAN 320
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 58/144 (40%), Gaps = 19/144 (13%)
Query: 290 TRNFSRDNI-----IGRGGYGNVYKGLLPDGS-EVALKRFKNCSAAGDAT---FKHEVEV 340
TR+F+ D+ +G+G +GNVY VALK + + E+E+
Sbjct: 17 TRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEI 76
Query: 341 IASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIA 400
A + H N++ L Y ++ ++ + G +Y L S +I
Sbjct: 77 QAHLHHPNILRLYNYFYDRRRI-----YLILEYAPRGELYKELQKSCT--FDEQRTATIM 129
Query: 401 LGTARGLAYLHFGAQPAIFHRDIK 424
A L Y H G + + HRDIK
Sbjct: 130 EELADALMYCH-GKK--VIHRDIK 150
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 36/129 (27%), Positives = 51/129 (39%), Gaps = 14/129 (10%)
Query: 299 IGRGGYGNVYKG--LLPDGSEVALKRFKNCSAAGDA-TFKHEVEVIASVRHVNLVALRGY 355
+G G Y VYKG L D VALK + G T EV ++ ++H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 356 CIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAYLHFGAQ 415
L + DL + ++ + KL RGLAY H +
Sbjct: 69 IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL-------FLFQLLRGLAYCH---R 118
Query: 416 PAIFHRDIK 424
+ HRD+K
Sbjct: 119 QKVLHRDLK 127
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 66/161 (40%), Gaps = 36/161 (22%)
Query: 278 LVRFTFDDIKKATRNFSRDNIIGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATF 334
+VR D+ N S IG G YG V Y L + VA+K+ + F
Sbjct: 17 MVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPF 63
Query: 335 KH---------EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA 385
+H E++++ RH N++ + A T + IV DLM+ +Y L
Sbjct: 64 EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKC 122
Query: 386 SN--GPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIK 424
+ + + L Q + RGL Y+H + HRD+K
Sbjct: 123 QHLSNDHICYFLYQIL-----RGLKYIHSA---NVLHRDLK 155
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 23/150 (15%)
Query: 280 RFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK-RFKNC--SAAGDATFK 335
+FT DD F +G+G +GNVY + ALK FK+ + +
Sbjct: 10 KFTIDD-------FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 336 HEVEVIASVRHVNLVALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWP 394
E+E+ + +RH N++ + Y +RI ++ + G +Y L +G +
Sbjct: 63 REIEIQSHLRHPNILRMYNY------FHDRKRIYLMLEFAPRGELYKEL-QKHG---RFD 112
Query: 395 LRQSIALGTARGLAYLHFGAQPAIFHRDIK 424
++S A LH+ + + HRDIK
Sbjct: 113 EQRSATFMEELADA-LHYCHERKVIHRDIK 141
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 36/161 (22%)
Query: 278 LVRFTFDDIKKATRNFSRDNIIGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATF 334
+VR D+ N S IG G YG V Y + + VA+K+ + F
Sbjct: 15 MVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPF 61
Query: 335 KH---------EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA 385
+H E++++ + RH N++ + A T + IV DLM+ +Y L
Sbjct: 62 EHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT 120
Query: 386 SN--GPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIK 424
+ + + L Q + RGL Y+H + HRD+K
Sbjct: 121 QHLSNDHICYFLYQIL-----RGLKYIHSA---NVLHRDLK 153
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 23/150 (15%)
Query: 280 RFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPDGSEV-ALK-RFKNC--SAAGDATFK 335
+FT DD F +G+G +GNVY + ALK FK+ + +
Sbjct: 11 KFTIDD-------FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 63
Query: 336 HEVEVIASVRHVNLVALRGYCIATTQLEGHQRI-IVCDLMKNGSVYDHLFASNGPKLSWP 394
E+E+ + +RH N++ + Y +RI ++ + G +Y L +G +
Sbjct: 64 REIEIQSHLRHPNILRMYNY------FHDRKRIYLMLEFAPRGELYKEL-QKHG---RFD 113
Query: 395 LRQSIALGTARGLAYLHFGAQPAIFHRDIK 424
++S A LH+ + + HRDIK
Sbjct: 114 EQRSATFMEELADA-LHYCHERKVIHRDIK 142
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 36/161 (22%)
Query: 278 LVRFTFDDIKKATRNFSRDNIIGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATF 334
+VR D+ N S IG G YG V Y + + VA+K+ + F
Sbjct: 15 MVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPF 61
Query: 335 KH---------EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA 385
+H E++++ + RH N++ + A T + IV DLM+ +Y L
Sbjct: 62 EHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT 120
Query: 386 SN--GPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIK 424
+ + + L Q + RGL Y+H + HRD+K
Sbjct: 121 QHLSNDHICYFLYQIL-----RGLKYIHSA---NVLHRDLK 153
>pdb|1GUB|A Chain A, Hinge-Bending Motion Of D-Allose Binding Protein From
Escherichia Coli: Three Open Conformations
Length = 288
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 5/77 (6%)
Query: 280 RFTFDDIKKATRNF----SRDNI-IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATF 334
+ D++KKA N + DN+ +G G + L +G EVA+ K +A+G+A
Sbjct: 93 KIDMDNLKKAGGNVEAFVTTDNVAVGAKGASFIIDKLGAEGGEVAIIEGKAGNASGEARR 152
Query: 335 KHEVEVIASVRHVNLVA 351
E + LVA
Sbjct: 153 NGATEAFKKASQIKLVA 169
>pdb|1RPJ|A Chain A, Crystal Structure Of D-Allose Binding Protein From
Escherichia Coli
pdb|1GUD|A Chain A, Hinge-Bending Motion Of D-Allose Binding Protein From
Escherichia Coli: Three Open Conformations
pdb|1GUD|B Chain B, Hinge-Bending Motion Of D-Allose Binding Protein From
Escherichia Coli: Three Open Conformations
Length = 288
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 5/77 (6%)
Query: 280 RFTFDDIKKATRNF----SRDNI-IGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATF 334
+ D++KKA N + DN+ +G G + L +G EVA+ K +A+G+A
Sbjct: 93 KIDMDNLKKAGGNVEAFVTTDNVAVGAKGASFIIDKLGAEGGEVAIIEGKAGNASGEARR 152
Query: 335 KHEVEVIASVRHVNLVA 351
E + LVA
Sbjct: 153 NGATEAFKKASQIKLVA 169
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 27/159 (16%)
Query: 274 ESTNLVRFTFDDIKKATRNFSRDNIIGRGGYGNVYKGLLPD----GSEVALKRFKNCSAA 329
ES++ + +DIKK F +G G + V +L + G A+K +
Sbjct: 8 ESSSSWKKQAEDIKKI---FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALK 61
Query: 330 G-DATFKHEVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFAS-- 386
G +++ ++E+ V+ ++H N+VAL + L +V L+ G ++D +
Sbjct: 62 GKESSIENEIAVLRKIKHENIVALEDIYESPNHL-----YLVMQLVSGGELFDRIVEKGF 116
Query: 387 -NGPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIK 424
S +RQ + + YLH + I HRD+K
Sbjct: 117 YTEKDASTLIRQVL-----DAVYYLH---RMGIVHRDLK 147
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y + + VA+K+ + F+H E++++ RH
Sbjct: 39 IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 88
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 89 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 142
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 143 RGLKYIHSA---NVLHRDLK 159
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y + + VA+K+ + F+H E++++ RH
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 81 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 134
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 135 RGLKYIHSA---NVLHRDLK 151
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y + + VA+K+ + F+H E++++ RH
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 81 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 134
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 135 RGLKYIHSA---NVLHRDLK 151
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 9/64 (14%)
Query: 299 IGRGGYGNVYKGLL--PDGSE----VALKRFKNCSAAGD--ATFKHEVEVIASVRHVNLV 350
+G +G VYKG L P E VA+K K+ A G F+HE + A ++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 351 ALRG 354
L G
Sbjct: 76 CLLG 79
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y + + VA+K+ + F+H E++++ RH
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 81 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 134
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 135 RGLKYIHSA---NVLHRDLK 151
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y + + VA+K+ + F+H E++++ RH
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 81 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 134
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 135 RGLKYIHSA---NVLHRDLK 151
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y + + VA+K+ + F+H E++++ RH
Sbjct: 33 IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 82
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 83 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 136
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 137 RGLKYIHSA---NVLHRDLK 153
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 33/140 (23%)
Query: 299 IGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATFKH---------EVEVIASVRH 346
IG G YG V Y + + VA+K+ + F+H E++++ RH
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 347 VNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASN--GPKLSWPLRQSIALGTA 404
N++ + A T + IV DLM+ +Y L + + + L Q +
Sbjct: 81 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 134
Query: 405 RGLAYLHFGAQPAIFHRDIK 424
RGL Y+H + HRD+K
Sbjct: 135 RGLKYIHSA---NVLHRDLK 151
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 36/161 (22%)
Query: 278 LVRFTFDDIKKATRNFSRDNIIGRGGYGNV---YKGLLPDGSEVALKRFKNCSAAGDATF 334
+VR D+ N S IG G YG V Y + + VA+K+ + F
Sbjct: 33 MVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPF 79
Query: 335 KH---------EVEVIASVRHVNLVALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFA 385
+H E++++ RH N++ + A T + IV DLM+ +Y L
Sbjct: 80 EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT 138
Query: 386 SN--GPKLSWPLRQSIALGTARGLAYLHFGAQPAIFHRDIK 424
+ + + L Q + RGL Y+H + HRD+K
Sbjct: 139 QHLSNDHICYFLYQIL-----RGLKYIHSA---NVLHRDLK 171
>pdb|1XVJ|A Chain A, Crystal Structure Of Rat Alpha-Parvalbumin D94sG98E MUTANT
pdb|1XVJ|B Chain B, Crystal Structure Of Rat Alpha-Parvalbumin D94sG98E MUTANT
Length = 109
Score = 30.0 bits (66), Expect = 2.6, Method: Composition-based stats.
Identities = 18/59 (30%), Positives = 27/59 (45%), Gaps = 2/59 (3%)
Query: 284 DDIKKATRNFSRDN--IIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEV 340
DD+KK +D I G++ KG D +++ K K AAGD ++EV
Sbjct: 41 DDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGSGKIEV 99
>pdb|4AZ4|A Chain A, E.Coli Deformylase With Co(Ii) And Hydrosulfide
Length = 186
Score = 29.6 bits (65), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 13/26 (50%), Positives = 18/26 (69%)
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKN 376
A G +A TQ++ HQRIIV D+ +N
Sbjct: 40 AEEGIGLAATQVDIHQRIIVIDVSEN 65
>pdb|4AL3|A Chain A, Peptide Deformylase (Co-Form) With Mercaptoethanol
Length = 186
Score = 29.6 bits (65), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 13/26 (50%), Positives = 18/26 (69%)
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKN 376
A G +A TQ++ HQRIIV D+ +N
Sbjct: 40 AEEGIGLAATQVDIHQRIIVIDVSEN 65
>pdb|1ULZ|A Chain A, Crystal Structure Of The Biotin Carboxylase Subunit Of
Pyruvate Carboxylase
Length = 451
Score = 29.6 bits (65), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 23/66 (34%), Positives = 33/66 (50%), Gaps = 4/66 (6%)
Query: 307 VYKGLLPDGSEVALKRFKNCSAAGDATFKHEVEVIASVRHVNLVALRGYCIATTQLEGH- 365
V K L+ + E+A++ + C G T EV ++ RHV L A Y I T L+ +
Sbjct: 2 VNKVLVANRGEIAVRIIRACKELGIPTVAIYNEVESTARHVKL-ADEAYMIGTDPLDTYL 60
Query: 366 --QRII 369
QRII
Sbjct: 61 NKQRII 66
>pdb|2W3T|A Chain A, Chloro Complex Of The Ni-Form Of E.Coli Deformylase
pdb|2W3U|A Chain A, Formate Complex Of The Ni-Form Of E.Coli Deformylase
Length = 188
Score = 29.6 bits (65), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 13/26 (50%), Positives = 18/26 (69%)
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKN 376
A G +A TQ++ HQRIIV D+ +N
Sbjct: 40 AEEGIGLAATQVDIHQRIIVIDVSEN 65
>pdb|1RJV|A Chain A, Solution Structure Of Human Alpha-Parvalbumin Refined With
A Paramagnetism-Based Strategy
pdb|1RK9|A Chain A, Solution Structure Of Human Alpha-Parvalbumin (Minimized
Average Structure)
Length = 110
Score = 29.3 bits (64), Expect = 3.8, Method: Composition-based stats.
Identities = 17/50 (34%), Positives = 23/50 (46%), Gaps = 2/50 (4%)
Query: 284 DDIKKATRNFSRDN--IIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGD 331
DD+KK +D I G + KG PD +++ K K AAGD
Sbjct: 42 DDVKKVFHMLDKDKSGFIEEDELGFILKGFSPDARDLSAKETKMLMAAGD 91
>pdb|4AL2|A Chain A, Peptide Deformylase (Ni-Form) With Hydrosulfide
pdb|4AL2|B Chain B, Peptide Deformylase (Ni-Form) With Hydrosulfide
pdb|4AL2|C Chain C, Peptide Deformylase (Ni-Form) With Hydrosulfide
Length = 186
Score = 29.3 bits (64), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 13/26 (50%), Positives = 18/26 (69%)
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKN 376
A G +A TQ++ HQRIIV D+ +N
Sbjct: 40 AEEGIGLAATQVDIHQRIIVIDVSEN 65
>pdb|1DEF|A Chain A, Peptide Deformylase Catalytic Core (Residues 1-147), Nmr,
9 Structures
pdb|2KMN|A Chain A, Solution Structure Of Peptide Deformylase Complexed With
Actinonin
Length = 147
Score = 29.3 bits (64), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 13/29 (44%), Positives = 19/29 (65%)
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKN 376
+ A G +A TQ++ HQRIIV D+ +N
Sbjct: 37 TMYAEEGIGLAATQVDIHQRIIVIDVSEN 65
>pdb|1ICJ|A Chain A, Pdf Protein Is Crystallized As Ni2+ Containing Form,
Cocrystallized With Inhibitor Polyethylene Glycol (Peg)
pdb|1ICJ|B Chain B, Pdf Protein Is Crystallized As Ni2+ Containing Form,
Cocrystallized With Inhibitor Polyethylene Glycol (Peg)
pdb|1ICJ|C Chain C, Pdf Protein Is Crystallized As Ni2+ Containing Form,
Cocrystallized With Inhibitor Polyethylene Glycol (Peg)
pdb|1BS4|A Chain A, Peptide Deformylase As Zn2+ Containing Form (Native) In
Complex With Inhibitor Polyethylene Glycol
pdb|1BS4|B Chain B, Peptide Deformylase As Zn2+ Containing Form (Native) In
Complex With Inhibitor Polyethylene Glycol
pdb|1BS4|C Chain C, Peptide Deformylase As Zn2+ Containing Form (Native) In
Complex With Inhibitor Polyethylene Glycol
pdb|1BS5|A Chain A, Peptide Deformylase As Zn2+ Containing Form
pdb|1BS5|B Chain B, Peptide Deformylase As Zn2+ Containing Form
pdb|1BS5|C Chain C, Peptide Deformylase As Zn2+ Containing Form
pdb|1BS6|A Chain A, Peptide Deformylase As Ni2+ Containing Form In Complex
With Tripeptide Met-Ala-Ser
pdb|1BS6|B Chain B, Peptide Deformylase As Ni2+ Containing Form In Complex
With Tripeptide Met-Ala-Ser
pdb|1BS6|C Chain C, Peptide Deformylase As Ni2+ Containing Form In Complex
With Tripeptide Met-Ala-Ser
pdb|1BS7|A Chain A, Peptide Deformylase As Ni2+ Containing Form
pdb|1BS7|B Chain B, Peptide Deformylase As Ni2+ Containing Form
pdb|1BS7|C Chain C, Peptide Deformylase As Ni2+ Containing Form
pdb|1BS8|A Chain A, Peptide Deformylase As Zn2+ Containing Form In Complex
With Tripeptide Met-Ala-Ser
pdb|1BS8|B Chain B, Peptide Deformylase As Zn2+ Containing Form In Complex
With Tripeptide Met-Ala-Ser
pdb|1BS8|C Chain C, Peptide Deformylase As Zn2+ Containing Form In Complex
With Tripeptide Met-Ala-Ser
pdb|1BSZ|A Chain A, Peptide Deformylase As Fe2+ Containing Form (Native) In
Complex With Inhibitor Polyethylene Glycol
pdb|1BSZ|B Chain B, Peptide Deformylase As Fe2+ Containing Form (Native) In
Complex With Inhibitor Polyethylene Glycol
pdb|1BSZ|C Chain C, Peptide Deformylase As Fe2+ Containing Form (Native) In
Complex With Inhibitor Polyethylene Glycol
pdb|1BSJ|A Chain A, Cobalt Deformylase Inhibitor Complex From E.Coli
pdb|1BSK|A Chain A, Zinc Deformylase Inhibitor Complex From E.Coli
pdb|1G27|A Chain A, Crystal Structure Of E.Coli Polypeptide Deformylase
Complexed With The Inhibitor Bb-3497
pdb|1G27|B Chain B, Crystal Structure Of E.Coli Polypeptide Deformylase
Complexed With The Inhibitor Bb-3497
pdb|1G27|C Chain C, Crystal Structure Of E.Coli Polypeptide Deformylase
Complexed With The Inhibitor Bb-3497
pdb|1G2A|A Chain A, The Crystal Structure Of E.Coli Peptide Deformylase
Complexed With Actinonin
pdb|1G2A|B Chain B, The Crystal Structure Of E.Coli Peptide Deformylase
Complexed With Actinonin
pdb|1G2A|C Chain C, The Crystal Structure Of E.Coli Peptide Deformylase
Complexed With Actinonin
pdb|1LRU|A Chain A, Crystal Structure Of E.Coli Peptide Deformylase Complexed
With Antibiotic Actinonin
pdb|1LRU|B Chain B, Crystal Structure Of E.Coli Peptide Deformylase Complexed
With Antibiotic Actinonin
pdb|1LRU|C Chain C, Crystal Structure Of E.Coli Peptide Deformylase Complexed
With Antibiotic Actinonin
pdb|1XEM|A Chain A, High Resolution Crystal Structure Of Escherichia Coli
Zinc- Peptide Deformylase Bound To Formate
pdb|1XEN|A Chain A, High Resolution Crystal Structure Of Escherichia Coli
Iron- Peptide Deformylase Bound To Formate
pdb|1XEO|A Chain A, High Resolution Crystals Structure Of Cobalt- Peptide
Deformylase Bound To Formate
pdb|2AI8|A Chain A, E.Coli Polypeptide Deformylase Complexed With Sb-485343
pdb|2AI8|B Chain B, E.Coli Polypeptide Deformylase Complexed With Sb-485343
pdb|2AI8|C Chain C, E.Coli Polypeptide Deformylase Complexed With Sb-485343
Length = 168
Score = 29.3 bits (64), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 13/29 (44%), Positives = 19/29 (65%)
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKN 376
+ A G +A TQ++ HQRIIV D+ +N
Sbjct: 37 TMYAEEGIGLAATQVDIHQRIIVIDVSEN 65
>pdb|2DEF|A Chain A, Peptide Deformylase Catalytic Core (Residues 1-147), Nmr,
20 Structures
Length = 147
Score = 29.3 bits (64), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 13/29 (44%), Positives = 19/29 (65%)
Query: 348 NLVALRGYCIATTQLEGHQRIIVCDLMKN 376
+ A G +A TQ++ HQRIIV D+ +N
Sbjct: 37 TMYAEEGIGLAATQVDIHQRIIVIDVSEN 65
>pdb|1DFF|A Chain A, Peptide Deformylase
Length = 164
Score = 29.3 bits (64), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 13/26 (50%), Positives = 18/26 (69%)
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKN 376
A G +A TQ++ HQRIIV D+ +N
Sbjct: 40 AEEGIGLAATQVDIHQRIIVIDVSEN 65
>pdb|3K6L|A Chain A, The Structure Of E.Coli Peptide Deformylase (Pdf) In
Complex With Peptidomimetic Ligand Bb2827
pdb|3K6L|B Chain B, The Structure Of E.Coli Peptide Deformylase (Pdf) In
Complex With Peptidomimetic Ligand Bb2827
pdb|3K6L|C Chain C, The Structure Of E.Coli Peptide Deformylase (Pdf) In
Complex With Peptidomimetic Ligand Bb2827
Length = 169
Score = 29.3 bits (64), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 13/26 (50%), Positives = 18/26 (69%)
Query: 351 ALRGYCIATTQLEGHQRIIVCDLMKN 376
A G +A TQ++ HQRIIV D+ +N
Sbjct: 41 AEEGIGLAATQVDIHQRIIVIDVSEN 66
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 33/135 (24%), Positives = 56/135 (41%), Gaps = 16/135 (11%)
Query: 292 NFSRDNIIGRGGYGNVYKGLLPDG--SEVALKRFKNCSAAGDATFKHEVEVIASVRHVNL 349
+F +D IG G +G L+ D E+ ++ AA D + E+ S+RH N+
Sbjct: 23 DFVKD--IGSGNFG--VARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78
Query: 350 VALRGYCIATTQLEGHQRIIVCDLMKNGSVYDHLFASNGPKLSWPLRQSIALGTARGLAY 409
V + + T L I+ + G +Y+ + N + S + G++Y
Sbjct: 79 VRFKEVILTPTHLA-----IIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 410 LHFGAQPAIFHRDIK 424
H I HRD+K
Sbjct: 132 CH---SMQICHRDLK 143
>pdb|3F45|A Chain A, Structure Of The R75a Mutant Of Rat Alpha-Parvalbumin
Length = 109
Score = 28.9 bits (63), Expect = 6.2, Method: Composition-based stats.
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 2/50 (4%)
Query: 284 DDIKKATRNFSRDN--IIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGD 331
DD+KK +D I G++ KG D ++++ K K AAGD
Sbjct: 41 DDVKKVFHILDKDKSGFIEEDELGSILKGFSSDAADLSAKETKTLMAAGD 90
>pdb|1S3P|A Chain A, Crystal Structure Of Rat Alpha-parvalbumin S55d/e59d
Mutant
Length = 109
Score = 28.5 bits (62), Expect = 6.9, Method: Composition-based stats.
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 2/50 (4%)
Query: 284 DDIKKATR--NFSRDNIIGRGGYGNVYKGLLPDGSEVALKRFKNCSAAGD 331
DD+KK + +D I G++ KG D +++ K K AAGD
Sbjct: 41 DDVKKVFHILDKDKDGFIDEDELGSILKGFSSDARDLSAKETKTLMAAGD 90
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.137 0.427
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,244,756
Number of Sequences: 62578
Number of extensions: 380506
Number of successful extensions: 1439
Number of sequences better than 100.0: 405
Number of HSP's better than 100.0 without gapping: 52
Number of HSP's successfully gapped in prelim test: 353
Number of HSP's that attempted gapping in prelim test: 1228
Number of HSP's gapped (non-prelim): 406
length of query: 425
length of database: 14,973,337
effective HSP length: 102
effective length of query: 323
effective length of database: 8,590,381
effective search space: 2774693063
effective search space used: 2774693063
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 53 (25.0 bits)